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ABSTRACT 
Behavioral Mechanisms of Pramipexole-Induced Impulsivity: 
Discrimination Processes Underlying Decision-Making 
by 
Patrick S. Johnson, Doctor of Philosophy 
Utah State University, 2012 
Major Professor: Gregory J. Madden, Ph.D. 
Department: Psychology 
 
 
 Faced with an intertemporal choice, an organism that chooses a “smaller-sooner” 
reinforcer over a “larger-later” reinforcer is said to behave impulsively. Individual 
differences in intertemporal choice are effectively modeled by generalized matching law 
and delay discounting equations that incorporate parameters corresponding to behavioral 
processes such as sensitivity to reinforcer amount or delay. By simulating changes in 
these processes and identifying conditions under which impulsive choice is likely to 
result, researchers are in a position to anticipate and examine potential behavioral 
mechanisms underlying clinical instances of impulsivity. Pramipexole, a dopamine 
agonist medication, is associated with reports of impulsive behavior in populations 
prescribed the drug, as well as in experimental subjects administered the compound prior 
to intertemporal choice sessions, although the latter findings are mixed. The present set of 
experiments was designed (a) to systematically replicate conditions under which 
   
 
 
  iv 
  
pramipexole increased impulsive choice, but also nonspecifically disrupted behavior, and 
(b) to elucidate behavioral mechanisms of pramipexole-induced impulsivity in rats. In 
Chapter 2, a behavioral task used previously by researchers reporting a nonspecific effect 
of pramipexole was modified to include procedural controls common in the intertemporal 
choice literature (centering response, no-delay sessions). In accord with previous 
findings, acute pramipexole nonspecifically disrupted choice behavior, while chronic 
pramipexole partially remediated elements of the disruption (i.e., decrease in initial-block 
choice). In Chapter 3, three experiments targeted behavioral processes critical for 
intertemporal choice. Experiment 1 evaluated the acute and chronic effects of 
pramipexole on rats’ sensitivity to relative reinforcer delays in a concurrent-chains 
procedure. Contrary to the predicted effect, the drug decreased this measure, indicating 
the possibility of impaired stimulus control. Experiments 2 and 3 assessed the drug effect 
on discrimination of response-reinforcer contingencies and of reinforcer amounts, 
respectively, and revealed deficits in accuracy of similar magnitude across both 
preparations. Collectively, the results of these experiments suggest that previous findings 
of pramipexole-induced impulsivity and nonspecific disruption of behavior can be 
explained as impairments in discrimination processes required for intertemporal choice. 
Although the generality of the present findings may be limited to experimental settings 
with nonhumans, they demonstrate the utility of quantitatively modeling impulsivity. 
(163 pages) 
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PUBLIC ABSTRACT 
Behavioral Mechanisms of Pramipexole-Induced Impulsivity: 
Discrimination Processes Underlying Decision-Making 
by 
Patrick S. Johnson, Doctor of Philosophy 
Utah State University, 2012 
Impulsivity represents a substantial and devastating cost to our economic, cultural, and 
physical prosperity. Using quantitative models of choice behavior, researchers are able to 
identify environmental conditions likely to promote impulsive decision-making. Such an 
approach is especially valuable in experimental efforts to better understand how drugs 
negatively affect choice in humans and nonhumans alike. For instance, pramipexole, a 
dopamine agonist medication prescribed for Parkinson’s disease, has been associated 
with reports of increased rates of impulsive behavior. By which behavioral mechanisms 
pramipexole achieves these effects is unknown and requires further investigation. 
 
The research reported herein sought to clarify pramipexole’s effects on impulsive 
decision-making in rats according to two objectives. First, the goal of the experiment 
presented in Chapter 2 was to systematically replicate a previous study that reported an 
effect of pramipexole that was inconsistent with the extant literature. Second, the goal of 
the three experiments presented in Chapter 3 was to isolate behavioral processes that 
could contribute to impulsive choice and to describe quantitatively the mechanism(s) by 
which pramipexole negatively affects decision-making. 
 
Results suggested that pramipexole significantly disrupted rats’ discrimination of the 
source of food reinforcement, as well as discrimination of the amount of food received. 
These impairments are theoretically capable of increasing the probability of impulsive 
choice and may underlie pramipexole’s effects as reported in the nonhuman drug 
literature. With respect to clinical instances of impulsive behavior, the present findings 
have limited generality. The approach documented herein, however, demonstrates the 
utility of quantitatively modeling aspects of impulsive decision-making in order to better 
understand complex drug effects. 
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 CHAPTER 1 
INTRODUCTION 
Defining Impulsivity 
Impulsivity represents a substantial and devastating cost to our economic, 
cultural, and physical prosperity. Recent developments suggest that financial decisions 
made by trusted institutions and businesses are easily swayed by the allure of immediate 
gratification, often at the expense of reasoned, long-term planning. Clean, alternative 
sources of energy remain underfunded and largely unexplored while the devastating 
consequences of current technologies remain relegated to a distant future. Substance 
abuse and unsafe sexual behaviors are prevalent despite life-threatening health risks and 
the positive benefits associated with abstinence. That examples such as these are so 
readily conjured speaks to the pervasiveness of impulsive decision-making in our 
everyday lives.  
Central to the problem of impulsivity, and all of the examples illustrated above, is 
choice between consequences that are immediately forthcoming and those that are 
conferred only after some delay has elapsed. In a relatively simple choice situation in 
which two positive reinforcers differ in the delay to their receipt but are otherwise 
identical, it is perhaps not surprising that all animals, including humans, prefer the more 
immediate of the two. Given the perils of an unpredictable environment, natural selection 
has presumably favored organisms that were unwilling to wait when an equal opportunity 
was presently available. Something similar can be said for quantitative differences in 
amount. Because evolutionary pressures favor preference for larger reinforcers over 
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smaller reinforcers, choice in the absence of delay is demonstrably straight-forward and 
in the direction of larger reinforcers. Note, however, that neither of these simple choices–
immediacy over delay or larger over smaller–constitutes an impulsive decision. 
Impulsivity, as well as self-control, can only be demonstrated in a choice situation 
that combines differences in delay and amount, also known as an intertemporal choice 
(Ainslie, 1975; Rachlin & Green, 1972). In a typical intertemporal choice, a smaller 
reinforcer amount available relatively immediately is contrasted against a larger 
reinforcer amount available after a longer delay. Figure 1-1 illustrates such an 
intertemporal choice, with the vertical height of the bars corresponding to their objective 
values (1 and 3 units) and the horizontal distance from the choice point, T1, to each bar 
corresponding to the delay to the reinforcer (1 s and 10 s, respectively). Because the 
value of a reinforcer has been demonstrated empirically to decay hyperbolically as a 
function of delay to its delivery (e.g., Mazur, 1987), choice at time T1 is between the 
discounted values of the reinforcers (see Madden & Johnson, 2010 for a primer). In 
principle, the organism should choose the reinforcer associated with the higher 
discounted value. Given repeated choices, however, distributed rather than exclusive 
choice is not uncommon, especially as the features of the choice alternatives increase in 
similarity to one another (Mazur, 2010). 
Under these conditions, individuals who prefer the “smaller-sooner” (SS) 
reinforcer because its value exceeds that of the other alternative at time T1 are said to 
behave impulsively, while those who prefer the “larger-later” (LL) reinforcer for the 
opposite reason are described as exhibiting “self-control.” It is worth noting that 
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Figure 1-1. A hypothetical intertemporal choice. At time T1, the organism faces a choice 
between a small reinforcer (1 unit) delivered relatively immediately (1 s) and a larger 
reinforcer (3 units) available after a longer delay (10 s). Because both reinforcers are 
delayed, their values are discounted at T1. 
 
impulsive choice represents just one of many “impulsivities.” Failures to inhibit a 
prepotent response (i.e., impulsive action; e.g., Diergaarde et al., 2008) or to attend to 
relevant stimuli (e.g., Robbins, 2002) satisfy equally well colloquial definitions of 
impulsivity and are potentially related to impulsive choice (Pattij, Schetters, Janssen, 
Wiskerke, & Schoffelmeer, 2009; Robinson et al., 2009; but see de Wit, 2009), which is 
the focus of the research presented herein. 
Based on the fundamental conflict arising from differences in delay and amount, 
researchers have advanced the study of impulsivity in a nonhuman laboratory context. In 
these preparations, nonhuman subjects, typically rats or pigeons, respond on levers or 
keys to make choices between reinforcers differing along these two dimensions. As in 
humans, the degree of preference for an SS reinforcer has been shown to differ both 
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across and within species (e.g., Green, Fry, & Myerson, 1994; Koffarnus & Woods, 
2011; Tobin & Logue, 1994). At present, the sources of these individual differences are 
not well understood. Regardless of their origin, individual differences in impulsivity pose 
an interesting challenge to models of choice behavior. The next section will show that 
contemporary efforts to quantitatively characterize choice in general and impulsive 
choice specifically have, in large part, met this challenge and in doing so provide 
researchers with testable predictions regarding the influence of certain environmental 
factors, such as drug administration, on impulsive decision-making. 
Quantitative Models of Choice and Impulsivity 
 All behavior may be conceptualized as choice (Herrnstein, 1970). Allocating time 
and effort to one activity necessarily detracts from time and effort devoted to alternative 
activities. How should one choose between multiple courses of action? Normative models 
of decision-making based on economic principles suggest that, given time constraints, 
organisms should attempt to maximize their returns (Herrnstein, 1990). One translation of 
this prediction in economic terms is that an organism should tailor its investment to an 
option based on its rate of return. Translated yet again into the terminology of behavior 
analysis, the proportion of responses allocated to a choice alternative should be 
determined by the proportion of reinforcement obtained from that alternative: 
     
  
     
 
  
     
.        (1) 
 In other words, Equation 1, better known as the matching law, states that the 
proportion of responding for an option (R1) is equal to (i.e., matches) the proportion of 
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reinforcement obtained from that alternative (r1; Herrnstein, 1961). Equation 1 can be 
rewritten to express the same relation as a ratio: 
     
  
  
 
  
  
 .     (2) 
As in Equation 1, Equation 2 predicts a linear relation between relative rates of 
reinforcement and relative responding. The particular schedule of reinforcement in use 
does not reduce the utility of Equation 2. For instance, concurrent ratio schedules of 
reinforcement (e.g., fixed-ratio) require an organism to emit an experimenter-specified 
number of responses prior to earning reinforcement. Under these circumstances, the 
organism should, as predicted by normative models, choose the richer alternative 
exclusively (i.e., complete the least work possible for the same amount of reinforcement). 
Because all reinforcement is obtained from a single source, and all responding occurred 
on the alternative that provided it, matching is obtained.  
Equation 2 also describes performance under concurrent interval schedules (e.g., 
variable-interval [VI]). On a VI schedule, reinforcement is earned only after an 
unpredictable amount of time has elapsed and the organism has responded on the 
apparatus. Because responding exclusively on a single operanda results in lower 
reinforcement rates (i.e., reinforcers available periodically on the other operanda are not 
obtained), responding on concurrent VI schedules adaptively occurs at high rates on both 
operanda. Assuming only reinforcement frequency differs between the concurrent VI 
schedules, the organism should match relative response allocation to relative 
reinforcement rates. Thus, in the cases of concurrent ratio and interval schedules of 
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reinforcement, response allocation consistent with perfect matching allows the organism 
to maximize obtained reinforcement and to satisfy normative economic models. 
 One weakness of the formulations above is that they represent what organisms 
should do. Although perfect matching is predicted, it is not always obtained. In fact, 
undermatching, in which response allocation favors the leaner of two alternatives more 
than is predicted, is a more typical result of matching studies (Baum, 1974). Based upon 
the psychophysical assertions of Stevens’s power law (Stevens, 1957), Baum proposed 
the generalized matching law to quantify individual differences in matching: 
        
  
  
        
  
  
       .       (3) 
Response allocation in Equation 3 remains a linear function of relative reinforcement 
rates, but with a slope of r and a y-intercept of log b. Unlike in Equations 1 and 2, the 
slope of the matching function in Equation 3, conceptualized as sensitivity to relative 
reinforcement rates, can depart from unity and thus accurately describe behavioral 
performances such as undermatching. Another advantage of Equation 3 is its ability to 
describe bias toward one response alternative (log b) resulting from factors other than the 
independent variable. By allowing these two parameters to vary, Equation 3 outperforms 
earlier versions of the matching law by more accurately modeling choice behavior. 
 The examples provided in the beginning of the previous section suggest that 
choice is not controlled exclusively by rates of reinforcement. Additional variables such 
as delay to reinforcement and reinforcement amount are critical determinants of choice 
behavior, especially in intertemporal choice situations. Soon after the development of 
Equation 1, Chung and Herrnstein (1967) equalized reinforcement rates and 
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demonstrated a negative relation between choice and delay to reinforcement. That is, as 
reinforcement associated with one option became increasingly delayed, choice 
increasingly favored the other alternative. Equation 3 can be expanded beyond 
reinforcement rates to include other parameters of interest, such as delay or amount: 
       
  
  
        
  
  
        
  
  
      .      (4) 
The concatenated matching law (Rachlin & Baum, 1969) extends the concept of 
sensitivity to all features of the choice situation. On one hand, if an organism is perfectly 
sensitive to all features of the choice situation (d and a = 1) and does not exhibit any 
biases (log b = 0), choice will reflect the sum of the reinforcer delay and amount ratios. 
On the other hand, if the organism is imperfectly sensitive to any aspect of the choice 
situation, this insensitivity will be reflected in the relevant sensitivity parameter. 
 By including parameters designed to describe the sensitivity of behavior to 
relative reinforcement delays and amounts, researchers extended matching accounts of 
behavior to intertemporal choice situations (Ito & Nakamura, 1998; Ito & Oyama, 1996; 
Logue, Peña-Correal, Rodriguez, & Kabela, 1986; Logue, Rodriguez, Peña-Correal, & 
Mauro, 1984; White & Pipe, 1987). Logue et al. (1984), for instance, used Equation 4 to 
compare relative sensitivities to delay and amount in pigeons that had received self-
control training and those that had not (Mazur & Logue, 1978). Logue and colleagues 
suggested that Equation 4 could be summarized as follows: 
         
  
  
      
  
  
 ,    (5) 
wherein relative response allocation (i.e., choice) is equivalent to the relative values of 
the two outcomes (i.e., the combined effects of reinforcement delays and amounts). At 
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the same time, however, the integration of these two frameworks was limited to 
concurrent-chains procedures and almost exclusively to concurrent VI schedules. 
 In a seminal paper, Mazur (1987) reiterated findings from the literature that 
choice in concurrent-chains procedures was influenced not only by features of terminal-
link schedules (e.g., reinforcement amount), but also the durations of initial-link 
schedules (e.g., Fantino, 1969). To minimize this “initial-link” effect, Mazur proposed 
using discrete-choice procedures in which a single response on either alternative initiated 
the reinforcement sequence. An important consequence of reducing the initial-link 
schedule to a single response is that response allocation within a trial is necessarily 
exclusive. Given the relation described in Equation 5, exclusive choice should result from 
the difference in relative reinforcer value (Ho, Mobini, Chiang, Bradshaw, & Szabadi, 
1999; Logue, 1988). 
 In addition to these procedural considerations, the primary contribution of Mazur 
(1987) was the formal description of the decay of reinforcer value resulting from the 
introduction of a delay to reinforcement. To assess this delay discounting phenomenon, 
Mazur used pigeons’ choices between 2 s and 6 s access to grain (Experiment 1). The 
delay to the smaller reinforcer amount (SS) was fixed by the experimenter across 
conditions, but was always of shorter duration than the delay to the larger reinforcer 
amount (LL), which varied as a function of the pigeon’s prior choices. For example, if the 
pigeon chose the SS reinforcer on two consecutive trials, the delay to the LL reinforcer 
was slightly decreased. If the LL reinforcer was chosen twice, then its delay was slightly 
increased. If the SS and LL reinforcers were chosen once each on consecutive trials, a 
   
 
 
  9 
  
pattern indicating indifference between the choice alternatives, then the LL delay 
remained unchanged. Once stable over several trials, these indifference points (LL 
delays) were plotted by Mazur as a function of the SS delay. Of four models 
hypothesized to describe the relation between reinforcer value and delay of 
reinforcement, the empirical data were most consistent with a hyperbolic model: 
        
 
    
         (6) 
In Equation 6, the subjective value of a reinforcer, V, of objective magnitude A declines 
as an inverse function of delay to reinforcement delivery D, a process illustrated in Figure 
1-1 and simulated in Figure 1-2. 
The rate at which value decays (i.e., the steepness of the curve in Figure 1-2) is 
described by k, a free parameter that varies across individuals as well as across states 
experienced by organisms (Odum & Bauman, 2010). Higher k estimates (i.e., steeper 
delay discounting) are often associated with drug dependency (Baker, Johnson, & Bickel, 
2003; Bickel, Odum, & Madden, 1999; Coffey, Gudleski, Saladin, & Brady, 2003; 
Heyman & Gibb, 2006; Johnson, Bickel, & Baker, 2007; Kirby & Petry, 2004; Kirby, 
Petry, & Bickel, 1999; Madden, Petry, Badger, & Bickel, 1997; Mitchell, 1999; Ohmura, 
Takahashi, & Kitamura, 2005; Petry, 2001; Reynolds, Richards, Horn, & Karraker, 2004) 
and treatment failure in abusing populations (Stanger et al., 2011; Washio et al., 2011; 
Yoon et al., 2007). 
Hyperbolic delay discounting has been replicated across species using a variety of 
discrete-choice procedures (e.g., Johnson, 2012; Reynolds & Schiffbauer, 2004; 
Richards, Mitchell, de Wit, & Seiden, 1997). One assumption of Equation 6, likely 
   
 
 
  10 
  
 
Figure 1-2. A hypothetical delay discounting curve. When delivered immediately, the 
reinforcer retains its full objective value. Increasing the delay to reinforcer delivery 
rapidly decreases the subjective value (V in Equation 6) of the reinforcer at a rate k in 
accordance with the hyperbolic model proposed by Mazur (1987). 
 
satisfied on most occasions, is that the choice behavior is perfectly sensitive to relative 
reinforcer amounts and delays in effect. Under certain conditions (e.g., drug 
administration), however, the assumption of perfect sensitivity may be violated and lead 
to poor model convergence. To accommodate departures from perfect sensitivity, 
researchers have proposed versions of Equation 6 that in many ways mirror the historical 
development of the generalized matching law (Equation 3) from the strict matching law 
(Equation 2). Specifically, these hyperboloid models, so-called for their approximation of 
hyperbolic discounting, include parameters for sensitivity to relative reinforcer amounts 
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(a) and sensitivity to relative delay to reinforcement (d; Green & Myerson, 2004; Locey 
& Dallery, 2009; Loewenstein & Prelec, 1992; Myerson & Green, 1995; Rachlin, 2006): 
        
  
       
        (7) 
Model comparisons between hyperboloid (Equation 7) and hyperbolic (Equation 6) 
discounting equations favor the former family and suggest that the assumption of perfect 
sensitivity is not always a prudent one (McKerchar, Green, & Myerson, 2010; 
McKerchar et al., 2009). Perhaps more importantly, the inclusion of sensitivity 
parameters in discounting models like Equation 7 unifies the logic once separating 
parallel efforts to model intertemporal choice using concurrent-chains (matching law) and 
discrete-choice (delay discounting) procedures. Reformulating Equation 4 to incorporate 
the empirical evidence for delay discounting into analyses of response allocation data 
obtained in concurrent-chains preparations (e.g., Pitts & Febbo, 2004): 
        
  
  
        
     
     
        
  
  
   (8) 
 According to the unified framework of Equations 7 and 8, intertemporal choice 
reflects not only the effects of delay discounting processes, but also related sensitivities to 
relative reinforcer amount and psychophysically scaled delay variables. The section that 
follows will attempt to demonstrate quantitatively how changes in these behavioral 
processes influence the relative values of SS and LL choice alternatives and, in effect, the 
outcome of intertemporal choice. Because little is known about the interaction between 
delay discounting rate (k) and the sensitivity parameters under consideration, discounting 
rate is assumed constant at 1 in the following simulations. In effect, changes in behavioral 
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processes such as sensitivities to relative reinforcer delays or relative reinforcer amounts, 
induced by drug administration for example, will be shown to qualify as candidate 
behavioral mechanisms of intertemporal choice. 
Behavioral Mechanisms of Intertemporal Choice 
 As discussed in preceding sections, organisms display consistent preferences for 
immediate over delayed sources of reinforcement. Likewise, organisms prefer large 
amounts of reinforcement over small amounts of reinforcement. Extrapolated to an 
intertemporal choice scenario, these “default” preferences interact and compete to 
determine decision-making. Using the ability of Equation 8 to capture individual 
differences (e.g., differences in delay discounting or sensitivity to relative reinforcer 
amounts or relative reinforcer delays), researchers can speculate about the conditions 
under which organisms will choose impulsively (all else being equal). Each of the 
following model simulations involves a behavioral process fundamental to impulsivity as 
evaluated in intertemporal choice. 
One reason why an individual might choose impulsively is if it displays enhanced 
sensitivity to relative reinforcer delays (i.e., d > 1). As an example, let us modify slightly 
the intertemporal choice depicted in Figure 1-1. In our new choice situation, an organism 
at time T1 must choose between R1, a SS reinforcer of 1 unit delivered after 2 s, and R2, a 
LL reinforcer of 3 units delivered after 6 s, and presumably does so on the basis of 
whichever alternative has the greater subjective value at T1. Assuming a delay 
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discounting rate of 1, and perfect sensitivity to both relative reinforcer amounts and 
relative reinforcer delays (d and a = 1), Equation 8 predicts: 
    
  
  
        
     
     
        
 
 
  
    
  
  
            
    
  
  
        
In this instance, the value of the LL reinforcer exceeds that of the SS reinforcer. This fact 
is verified by solving for V1 and V2 according to Equation 7, which results in discounted 
values of 0.33 and 0.43, respectively–the logarithmic ratio of which is equal to -0.11. 
Because the organism should choose the reinforcer with the greater relative value, V2, 
which reflects the LL reinforcer, is selected. 
Assuming the same intertemporal choice scenario, which choice alternative would 
be chosen should the same organism display enhanced sensitivity to relative reinforcer 
delays (e.g., d = 1.5)? Equation 8 now predicts: 
    
  
  
          
     
     
        
 
 
  
    
  
  
            
    
  
  
       
Under conditions in which enhanced sensitivity to relative reinforcer delays is observed, 
the organism will reverse its previously demonstrated preference for R2 (the LL 
reinforcer) and favor the more valuable reinforcer associated with R1 (the SS reinforcer). 
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This reversal can again be confirmed in the context of Equation 7, which arrives at values 
of 0.19 and 0.16 for R1 and R2, respectively; the log ratio of these values is also 0.07. 
 To demonstrate further the influence of this sensitivity parameter on intertemporal 
choice, simulations based on Equations 7 and 8 were conducted across a range of delay 
sensitivity values. Specifically, an approach similar to that of Mazur (1987) was adopted 
to estimate LL delays at which a hypothetical organism with k and a = 1 was indifferent 
between R1 and R2. That is, given an “experimenter-programmed” delay to 1 reinforcer 
unit (SS), at what delay to 3 units (LL) would V1 = V2? The results of the simulations are 
shown in Figure 1-3. When sensitivity to relative reinforcer delays was low (e.g., d = 
0.5), the LL delay at indifference tended to be of longer duration in comparison to LL 
delays given the same SS delay but with higher sensitivity values. In other words, as 
sensitivity to relative reinforcer delays increases, the LL delay at indifference for any SS 
delay grows shorter. Poor tolerance of LL delays is a hallmark of increased impulsivity in 
an intertemporal choice context and is consistent with the predictions of the model. 
The functions shown in Figure 1-3 also accord with the predictions of hyperbolic 
delay discounting made by Mazur (1987). In his Figure 3.3, Mazur illustrated functions 
consistent with four competing models of the relation between reinforcer delay and value. 
Hyperbolic discounting (Equation 6), which his empirical data confirmed, required (a) 
that the slope of the function relating LL delay at indifference and SS delay be greater 
than 1, and (b) a non-zero y-intercept. Although Mazur did not originally consider 
Equation 7, the model also predicts a linear relation between reinforcer delays with slope 
> 1 and y-intercept ≠ 0 and when d and a = 1 reduces to Equation 6. As such, the 
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Figure 1-3. Simulated effects of changes in sensitivity to relative reinforcer delay on LL 
indifference delays. This delay-delay plot, similar to those reported in Mazur (1987), 
shows that as sensitivity to relative reinforcer delays (d) in Equation 8 increases, the 
organism is indifferent between progressively shorter LL delays (y-axis), a behavioral 
pattern consistent with increased impulsivity. 
  
simulations conducted above serve to advance our understanding of the role of sensitivity 
to relative reinforcer delay in intertemporal choice situations. 
Similar logic predicts increased impulsive choice if an individual displays 
diminished sensitivity to relative reinforcer amount (i.e., a < 1). Once again, the modified 
intertemporal choice depicted in Figure 1-1 serves as our example. For an organism with 
perfect sensitivity to relative reinforcer delay and amount (d and a = 1), choice at time T1 
between R1, a SS of 1 unit delivered after 2 s, and R2, a LL of 3 units delivered after 6 s, 
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should reflect the objective values held by these parameters. As before, Equation 8 
predicts: 
    
  
  
        
     
     
        
 
 
  
    
  
  
            
    
  
  
       . 
The hypothetical organism in this example is predicted to choose R2, the LL reinforcer of 
subjective value 0.43, over R1, the SS reinforcer of subjective value 0.33. 
According to Equation 8, diminished sensitivity to relative reinforcer amount 
should increase the frequency of SS choice. If a = 0.5, then Equation 8 predicts: 
    
  
  
        
     
     
          
 
 
  
    
  
  
            
    
  
  
      . 
Now the discounted values of the reinforcers are 0.33 and 0.25 for the SS and LL 
reinforcers, respectively, the logarithmic ratio of which is 0.13. Reducing sensitivity to 
relative reinforcer amount, like enhancing sensitivity to relative reinforcer delay, also 
produces a reversal in preference. 
 The simulations previously used to predict the relation between sensitivity to 
relative reinforcer delay and LL delays at indifference were conducted across a range of 
amount-sensitivity values. Figure 1-4 depicts the results. As sensitivity to reinforcer 
amount decreases, LL delays become progressively shorter, indicating that sensitivity to  
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Figure 1-4. Simulated effects of changes in sensitivity to relative reinforcer amount on 
LL indifference delays. This delay-delay plot shows that as sensitivity to relative 
reinforcer amount (a) in Equation 8 increases, the organism is indifferent between 
progressively shorter LL delays (y-axis), a behavioral pattern consistent with increased 
impulsivity. 
 
relative reinforcer amount increases the likelihood of SS choice. 
The functions shown in Figure 1-4 are, like those of Figure 1-3, consistent with 
the predictions of hyperbolic discounting (Equations 6 and 7); in all cases, the slopes of 
the functions exceeded 1 and the y-intercepts were greater than zero. Comparing the two 
figures reveals the inverse relation between sensitivity to relative reinforcer delay and 
amount predicted by Equation 8. For example, by halving amount sensitivity (i.e., a = 
0.5), one obtains the same set of LL delays at indifference as would be produced by 
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doubling delay sensitivity (i.e., d = 2.0). By and large, the simulations conducted with 
sensitivity to relative reinforcer amount concur with those involving sensitivity to relative 
reinforcer delay: By manipulating these parameters in an ordinal manner, the relative 
value of a SS reinforcer can be shown to exceed that of LL reinforcer, whereas this was 
not the case under conditions of perfect sensitivity. Specifically, Equations 7 and 8 
predict that enhanced sensitivity to relative reinforcer delay and diminished sensitivity to 
relative reinforcer amount are likely to increase the frequency of SS choice. 
Although organisms may vary naturally in the degree to which choice is sensitive 
to differences in reinforcer delays and amounts, experimental manipulations such as 
presession drug administration have been shown to induce changes in sensitivity likely to 
promote impulsive choice (Locey & Dallery, 2011; Maguire, Rodewald, Hughes, & Pitts, 
2009; Pitts & Febbo, 2004). As such, the quantitative framework outlined above serves as 
a practical foundation for the elucidation of behavioral mechanisms of drug action 
(Branch, 1984). Elucidation of behavioral mechanisms of drug action involves the 
comparison of baseline (nondrug) performances to those resulting from drug 
administration, typically with an emphasis on a specific behavioral process thought to be 
responsible for the behavioral change (e.g., sensitivity to relative delay or amount). 
Identifying a drug’s capacity to alter baseline levels of impulsivity is of apparent import 
not just for compounds with potential abuse liability, but also for clinically prescribed 
compounds. The next section introduces one such compound of interest, the dopamine 
(DA) agonist pramipexole (PPX), thought to affect the frequency of impulsive behavior 
in clinical and experimental settings with human and nonhuman subjects. Implications for 
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applying quantitative models of choice (Equations 7 and 8) in an effort to isolate and 
identify the source of PPX’s effects on impulsivity will be explored. 
Pramipexole and Impulsivity 
PPX is a DA agonist prescribed primarily as part of DA-replacement therapy for 
Parkinson’s disease (PD), but has documented efficacy in restless legs syndrome (RLS; 
Winkelman et al., 2006), fibromyalgia (Holman & Myers, 2005), and depression (Inoue 
et al., 2010; Zarate et al., 2004). PPX has particular affinity for D2-family receptors, 
specifically the D2 and D3 subtypes (Bennet & Piercey, 1999; Kvernmo, Härtter, & 
Bürger, 2006), which are predominantly expressed along the mesocorticolimbic pathway. 
Projections of dopaminergic neurons in these brain regions and their abundance of D2 and 
D3 receptors subtypes have recently garnered attention for their influential role in 
learning (Waelti, Dickinson, & Schultz, 2001) and decision-making processes 
(Heidbreder et al., 2007; St. Onge & Floresco, 2009). Impairment of these processes 
following administration of PPX and other DA agonists has increased interest in the 
contributions of DA receptor pharmacology to complex behavioral performances such as 
impulsive choice (Abler, Hahlbrock, Unrath, Grön, & Kassubek, 2009; Boulougouris, 
Castañé, & Robbins, 2009; Pizzagalli et al., 2008; see Smith, Becker, & Kapur, 2005, for 
a theoretical proposal). 
The possible relation between PPX and impulsivity was initially identified 
through clinical reports of emergent pathological gambling (e.g., Dodd et al., 2005; 
Driver-Dunckley, Samanta, & Stacy, 2003), hypersexuality (e.g., Giladi, Weitzman, 
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Schreiber, Shabtai, & Peretz, 2007; Klos, Bower, Josephs, Matsumoto, & Ahlskog, 
2005), binge eating (Hassan et al., 2011), and compulsive shopping (Cornelius, 
Tippmann-Peikert, Slocumb, Frerichs, & Silber, 2010) in patients taking the drug for PD 
or RLS (Voon et al., 2011). A comprehensive cross-sectional survey of more than 3000 
PD patients revealed that individuals taking DA medications like PPX were 2-3.5 times 
more likely than those not taking DA medications to present with impulse control 
disordered behavior (ICD; Weintraub et al., 2010). With respect to gambling specifically, 
a survey of the Food and Drug Administration’s Adverse Event Database found that 58% 
of drug-related incidents of pathological gambling involved PPX (Szarfman, 
Doraiswamy, Tonning, & Levine, 2006). Clinical findings are, however, strictly 
correlational as they do not control for threats to internal validity (e.g., maturation, 
selection), and therefore do not satisfy the stringent requirements of experimental 
evidence. These shortcomings notwithstanding, ICDs tend to subside shortly after 
decreasing or discontinuing DA medications (Avila, Cardona, Martín-Baranera, Bello, & 
Sastre, 2011; Mamikonyan et al., 2008), which further suggests the involvement of D2/D3 
stimulation in the development of impulsive behavior. 
Experimental results from studies using human participants with and without PD 
have provided mixed support for the hypothesis that PPX induces impulsivity. In patients 
with PD, Voon et al. (2010) found stronger preference for SS over LL reinforcement in 
patients who had previously reported a DA-related ICD versus those who had not, but 
only when medication regimens were in effect (i.e., no significant difference between 
groups in off-state). This finding of increased SS preference in PD patients reporting 
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ICDs but not in those without ICDs has since been replicated by Housden, O’Sullivan, 
Joyce, Lees, and Roiser (2010) and suggests that PPX may enhance pre-existing 
neuroanatomical susceptibilities in certain individuals to behave impulsively or take risks 
(e.g., Rao et al., 2010; Voon et al., 2011). One factor that does not appear to determine 
the effect of PPX and other DA medications is whether individuals are diagnosed with 
PD; neither Voon et al. nor Housden et al. reported significant differences in impulsivity 
between PD patients without ICDs and matched controls when the former group was 
“on” (both studies) or “off” the DA medication (Voon et al., 2011; but see Milenkova et 
al., 2011 for a PD-control difference, regardless of medication status). Nonetheless, much 
remains for clarification regarding the linkage between PD and impulsivity. 
Two studies have investigated the effects of PPX on impulsivity (Hamidovic, 
Kang, & de Wit, 2008) and risk taking (Riba, Krämer, Heldmann, Richter, & Münte, 
2008) in healthy human volunteers. Hamidovic et al. (2008) found no effect of either low 
(0.25 mg) or moderate (0.5 mg) doses of PPX on intertemporal choice compared to 
within-subject placebo. However, a nonsignificant trend toward increased impulsivity 
suggested that the effect could have achieved significance had their sample size (n = 8) 
been larger. Riba et al. (2008) detected a significant increase in the likelihood that 
participants would take a gambling-related risk (i.e., wager a large amount) following an 
unexpectedly large win after taking PPX (0.5 mg) compared to their own performances 
under placebo. A third study investigated the effects of the naturally-occurring DA 
precursor L-DOPA on intertemporal choice in healthy adults and detected significant 
increases in degree of SS preference relative to placebo conditions (Pine, Shiner, 
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Seymour, & Dolan, 2010). Although the investigation of neurologically intact 
populations removes from consideration the potential influence of PD on PPX-, or more 
generally DA-, induced impulsivity, human drug research is still potentially contaminated 
by confounding variables (e.g., genetic predisposition, learning history). 
To address these concerns, researchers have initiated the use of nonhuman models 
to address questions regarding PPX and impulsivity. Compared to human participants, 
nonhuman models afford researchers a greater degree of experimental control over 
variables such as life history, diet, and sleep cycle (Sidman, 1960). To the extent that 
nonhuman physiology involved in decision-making is homologous to that of humans, 
findings of nonhuman studies are generally applicable to human choice situations. 
Nonhuman models, therefore, permit the investigation of drug-behavior interactions in 
the absence of complex and often confounding aspects of human behavior. 
Because PPX has been associated with emergent pathological gambling in clinical 
populations, researchers have attempted to develop valid nonhuman models of this 
behavior. Johnson, Madden, Brewer, Pinkston, and Fowler (2011) and Johnson, Madden, 
and Stein (2012) arranged for rats choices to earn identical food reinforcers upon 
completion of predictable or unpredictable amounts of work, the latter of which captured 
functional aspects of gambling ventures available to humans. In separate nondrug 
baseline conditions, rats either preferred the predictable amount of work (low-gambling) 
or the unpredictable amount of work (high-gambling). In both studies, PPX increased 
rats’ choice for the gambling-like schedule of reinforcement above saline levels in the 
low-gambling baseline condition; in neither case did PPX affect significantly choice in 
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the high-gambling baseline condition. Employing intracranial self-stimulation (ICSS) as a 
reinforcer rather than food, Rokosik and Napier (2012) evaluated the effects of 
chronically administered PPX on rats’ discounting of probabilistic outcomes. Interaction 
between the drug and PD-like symptoms was investigated in one group of rats following 
intrastriatal 6-OHDA-induced lesions, a commonly used animal model of PD (Schober, 
2004; Simola, Morelli, & Carta, 2007); another group of rats received sham lesions (i.e., 
all but 6-OHDA injection). Under saline conditions, all rats’ choice for a large, but 
probabilistic period of ICSS declined characteristically as a function of the reinforcer 
probability. During the chronic assessment, PPX increased choice for this same reinforcer 
regardless of whether rats were PD-like or sham, suggesting that the drug decreased rats’ 
sensitivity to the negative effects of risk. 
Related nonhuman work has examined PPX effects on intertemporal choice in 
rats. Madden, Johnson, Brewer, Pinkston, and Fowler (2010) examined the effects of 
PPX on rats’ intertemporal choices using a fixed-delay procedure. In a fixed-delay 
procedure, subjects make repeated choices between SS and LL reinforcers whose features 
do not change within session (e.g., fixed LL delay). Using a within-subject experimental 
design, rats experienced two conditions, one in which their baseline preference favored 
the SS reinforcer (1 food pellet after 0.01 s) and one in which it favored the LL reinforcer 
(3 food pellets after X s). Preference was generated by titration of the LL delay (X s) 
between conditions until preference stabilized at a given delay within a baseline. Madden 
et al. (2010) then administered PPX (0.1, 0.18, and 0.3 mg/kg) prior to sessions. The 
results are shown in Figure 1-5. When baseline preference favored the LL reinforcer  
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Figure 1-5. Effects of PPX on intertemporal choice in rats (Madden et al., 2010). PPX 
increased rats’ preference for a SS reinforcer in a condition of baseline LL preference 
(open circles; self-control baseline). SS preference was unaffected by PPX in a control 
condition of baseline SS preference (closed circles; impulsive baseline). Data represent 
group means (±SEM). Copyright © 2010 by the American Psychological Association.  
Reproduced with permission. The official citation that should be used in referencing this 
material is Madden, G. J., Johnson, P. S., Brewer, A. T., Pinkston, J. W., & Fowler, S. C. 
(2010). Effects of pramipexole on impulsive choice in male wistar rats. Experimental and 
Clinical Psychopharmacology, 18(3), 267-276. doi:10.1037/a0019244. No further 
reproduction or distribution is permitted without written permission from the American 
Psychological Association. 
 
 
(self-control baseline), PPX significantly and dose-dependently increased preference for 
the SS reinforcer above saline levels. PPX did not significantly affect preference relative 
to saline when the same rats preferred the SS reinforcer. While the former result of 
increased SS preference is intriguing with respect to the hypothesized relation between 
PPX and impulsivity, the latter finding also suggests that PPX does not simply impair 
decision-making regardless of underlying preference. If so-called nonspecific effects 
(e.g., poor discrimination) were influential, preference in both baselines would have 
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trended toward indifference (i.e., 50% choice). Because the drug effect was only 
observed in one of the two baselines, the authors concluded that PPX’s effects on 
impulsivity in a nonhuman model were generally consistent with clinically-documented 
development of impulsive behavior. 
A subsequent study by Koffarnus, Newman, Grundt, Rice, and Woods (2011) 
investigated the effects of a number of DA compounds on intertemporal choice. Rather 
than the fixed-delay procedure of Madden et al. (2010), Koffarnus et al. (2011) employed 
an increasing-delay procedure. In an increasing-delay procedure, the LL delay typically 
increases across multiple blocks of trials within individual sessions, enabling researchers 
to evaluate drug effects across a range of delays (Evenden & Ryan, 1996). Additionally, 
Koffarnus et al. (2011) delivered 1 or 3 sucrose pellets as their reinforcers, the larger 
being available after 0, 10, 20, 40, or 60 s. Data from this experiment are shown in Figure 
1-6. Preference for the LL reinforcer under baseline (nondrug) and saline conditions was 
highest early in sessions (0 s) and declined characteristically as the LL delay increased. 
PPX (0.032 and 0.1 mg/kg) did not significantly affect intertemporal choice, although 
trend-level shifts toward increased SS were visually apparent at intermediate LL delays. 
The highest PPX dose (0.32 mg/kg) significantly increased SS choice across all choice 
blocks, but did so even in the initial trial block (1 vs. 3 pellets, both immediate). The 
latter finding could reflect a decrease in sensitivity to relative reinforcer amount, a 
nonspecific impairment of discrimination, or both. In sum, the findings of Koffarnus et 
al. (2011) suggest that at lower doses PPX has little to no effect on impulsive choice, 
while at higher doses PPX affects sensitivity to relative reinforcer amount or impairs 
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Figure 1-6. Effects of PPX on intertemporal choice in rats (Koffarnus et al., 2011). Low 
PPX doses (0.032 & 0.1) did not affect rats’ preferences across a range of LL delays. A 
high PPX dose (0.32) shifted preference toward indifference. Data are group means 
(±SEM). Adapted from “Effects of Selective Dopaminergic Compounds on a Delay-
discounting Task,” by M. N. Koffarnus, A. H. Newman, P. Grundt, K. C. Rice, and J. H. 
Woods, 2011, Behavioural Pharmacology, 22, p. 306. Copyright 2011 by Wolters 
Kluwer Health. 
 
discrimination of the choice alternatives, both of which may result in increased SS 
preference. 
In summary, the DA agonist medication PPX and its effects on impulsive 
behavior are unclear and in need of further elucidation. On one hand, PPX appears to 
increase the probability of impulsive behaviors such as pathological gambling and 
hypersexuality in clinical populations. On the other hand, when administered under 
rigorous experimental protocols, PPX increases impulsivity (Madden et al., 2010; Riba et 
al., 2008), has no effect (Hamidovic et al., 2008), or affects preference in a manner 
consistent with nonspecific impairment of discrimination (Koffarnus et al., 2011). 
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Reconciliation of these discrepant results depends upon the identification of behavioral 
mechanisms influential in determining the form of the drug effect. Ultimately, a 
consistent, unified theory regarding the interaction between PPX and impulsive decision-
making is desired. 
The final section will outline a research agenda that is sympathetic to these goals. 
Informed by preceding discussions regarding the theoretical, procedural, and empirical 
bases of impulsivity, the present series of experiments will attempt to elucidate the 
behavioral mechanisms underlying PPX-induced impulsivity. Conceptually, the research 
presented herein will emphasize the role of behavioral processes thought to be critical to 
choice situations likely to produce impulsivity. 
The Research Agenda 
 At present, experimental evidence regarding the effects of PPX on impulsivity is 
mixed and in need of clarification. With respect to studies investigating the drug in 
nonhumans, only two studies have been conducted using different experimental 
procedures (Koffarnus et al., 2011; Madden et al., 2010). In short, Madden et al. (2010) 
found that PPX increased SS choice when nondrug preference for the SS reinforcer was 
low. In a separate condition in which nondrug SS choice was high, SS choice in the same 
rats was unaffected by the drug. This pattern of results suggested that PPX selectively 
increased impulsivity without nonspecifically disrupting baseline preferences. Koffarnus 
et al. (2011) found that PPX did not affect SS choice (low doses), decreased sensitivity to 
relative reinforcer amount, or nonspecifically disrupted discrimination (high dose). This 
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pattern of results is in disagreement with the results of Madden et al. (2010), which 
forwarded an account of PPX-induced impulsivity independent of nonspecific drug 
effects. 
 Given the conflicting nature of these reports, the research presented herein was 
conducted in an effort to further evaluate the experimental conditions under which PPX-
induced impulsivity is likely to be observed. Although frequently employed by 
researchers interested in the effects of pharmacological variables on decision-making, the 
methods used by Koffarnus et al. (2011) omitted some procedures often used in studies 
using the increasing-delay procedure (no-delay sessions, centering response prior to 
choice), the absence of which may have influenced the form of the obtained preference 
functions. The goal of Chapter 2 was therefore to establish the validity of the findings 
reported by Koffarnus et al. (2011) by systematically replicating the increasing-delay 
procedure in a manner more commonly arranged in the extant drug literature. 
A recurring theme throughout the subsequent experiments as presented in Chapter 
3 was the quantification of behavioral processes under nondrug and saline conditions and 
following subsequent PPX administration. A change in the behavioral process–that is, the 
manner in which environmental input is processed into behavioral output–constitutes a 
potential behavioral mechanism underlying PPX-induced impulsivity. Experiment 1 
targeted specifically the capacity of PPX to modulate sensitivity to relative reinforcer 
delay, one of two primary behavioral processes believed to underlie impulsive decision-
making (see above simulations). Experiments 2 and 3 evaluated the effects of PPX on 
elementary discrimination processes, specifically the discrimination of responses 
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producing reinforcement (left/right levers) and the discrimination of reinforcer amounts 
(small/large), respectively. In theory, each of these behavioral processes is critical to 
decision-making and, as such, may contribute to clinical and experimental manifestations 
of increased impulsivity. 
Although the PPX effects reported previously were produced via acute 
administration, the present research explored the drug effect under chronic administration 
in addition to acute administration where appropriate. The rationale for this additional 
manipulation was twofold. First, clinical populations administer PPX chronically and 
frequently enough to maintain beneficial levels (Antonini & Calandrella, 2011), a 
variable that has not yet been explored in nonhuman PPX studies of intertemporal choice. 
Second, acute PPX administration significantly alters the behavior of DA neurons, 
whereas chronic PPX administration restores neuronal activity to near-baseline levels 
(Chernoloz, El Mansari, & Blier, 2009; Maj, Rogóz, Margas, Kata, & Dziedzicka-
Wasylewska, 2000), an effect that may influence the presence or absence of any 
nonspecific drug effects. 
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CHAPTER 2 
EFFECTS OF PRAMIPEXOLE ON INTERTEMPORAL CHOICE
1
 
Abstract 
 Pramipexole (PPX), a D2/D3 dopamine agonist medication prescribed as 
pharmacotherapy for a range of clinical disorders, has been associated with an increase in 
the frequency of impulsive behaviors. Two experiments using nonhuman subjects have 
evaluated the drug’s acute effect on intertemporal choice, wherein rats chose between a 
small amount of reinforcement delivered immediately and a larger amount delivered 
following a delay. Madden et al. (2010) reported PPX-induced increases in rats’ choice of 
the small, immediate reinforcer (i.e., impulsive choice); Koffarnus et al. (2011) reported 
that PPX may have nonspecifically disrupted rats’ decision-making. The procedures 
employed in the latter experiment omitted features traditionally included by other 
researchers using the increasing-delay procedure (no-delay sessions, centering response), 
the absence of which may have influenced Koffarnus and others’ (2011) findings. The 
present experiment systematically replicated the procedures of Koffarnus et al. (2011), 
including these procedural features, in male Wistar rats. At higher doses (0.1-0.3 mg/kg), 
acute PPX disrupted rats’ choice between 1 and 3 food pellets delivered immediately in a 
manner consistent with Koffarnus et al. (2011) and indicative of nonspecific impairment 
of choice. At lower doses (0.01 and 0.03 mg/kg), acute PPX did not disrupt rats’ initial-
block choice and choice at nonzero delays nonsignificantly trended toward increased 
                                                 
1
 Coauthored with Gregory J. Madden, Adam T. Brewer, Jonathan W. Pinkston, and 
Stephen C. Fowler. 
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impulsive choice relative to saline. This pattern of results reproduces the primary findings 
of Koffarnus et al. (2011). Chronic PPX (0.1 and 0.3 mg/kg), which was not investigated 
in either of the earlier reports, partially reduced disruptions observed in the acute 
assessment. Interactions between PPX and the procedures used by Madden et al. (2010) 
and Koffarnus et al. (2011) likely underlie mixed findings in the literature. Identifying 
behavioral mechanisms of PPX-induced impulsivity common to both procedures may 
serve to unify these divergent outcomes. 
Introduction 
Clinical reports have implicated the D2/D3 dopamine (DA) agonist pramipexole 
(PPX) in the development of impulse control disordered behaviors (ICDs). Among ICDs 
reported are pathological gambling (e.g., Dodd et al., 2005; Driver-Dunckley et al., 
2003), hypersexuality (e.g., Giladi et al., 2007; Klos et al., 2005), and compulsive eating 
or shopping (Cornelius et al., 2010; Hassan et al., 2011). Individuals prescribed the drug 
as pharmacotherapy for Parkinson’s disease, restless legs syndrome, fibromyalgia, and 
treatment-resistant depression sometimes report the appearance of ICDs shortly after 
initiation of the regimen and resolution of the behavior coinciding with titration or 
discontinuation of PPX and other dopamine agonists (e.g., Avila et al., 2011). 
Researchers have evaluated experimentally the effects of PPX on impulsive 
decision-making in humans with and without PD. Voon et al. (2010) and Housden et al. 
(2010) assessed delay discounting of PD patients with and without ICDs and reported 
significantly steeper discounting among the PD-ICD group but only when DA 
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medications were in use. Delay discounting of PD patients not reporting ICDs did not 
differ significantly from that of matched non-PD controls in either study regardless of 
DA status (“on” vs. “off”), suggesting that PD is not a necessary condition for observing 
ICDs. Two studies have examined aspects of impulsivity in healthy volunteers 
administered PPX. Hamidovic et al. (2008) observed only trend-level shifts in within-
subject rates of delay discounting on and off PPX. Likewise, Riba et al. (2008) detected a 
significant effect of PPX in only one behavioral measure of their gambling task, the 
probability that participants would place a large bet following an unexpectedly large win. 
Nonhuman models of impulsive decision-making have also been used to evaluate 
the putative impulsivity-inducing effects of PPX. Madden et al. (2010) administered PPX 
acutely prior to sessions in which male rats made intertemporal choices for either small, 
immediate food reinforcers or larger, delayed food reinforcers. Against a nondrug 
baseline of preference for the “larger-later” (LL) reinforcer, PPX increased rats’ choice of 
the “smaller-sooner” (SS) reinforcer, the impulsive choice. The same PPX doses did not 
affect choice in a control condition in which baseline preference favored the SS 
reinforcer. Koffarnus et al. (2011) administered a range of dopaminergic compounds, 
including PPX, to male rats in a similar intertemporal choice procedure. Across the same 
range of PPX doses investigated by Madden et al. (2010), rats’ choice for a SS reinforcer 
either did not achieve statistical significance from saline vehicle (low doses) or was 
nonspecifically disrupted, indicating a possible impairment in stimulus control (high 
dose). At face value, the findings of Madden et al. (2010) and Koffarnus et al. (2011) are 
contradictory. However, the possibility that procedural differences are responsible for this 
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disagreement should be considered. Additionally, each set of results represents only a 
single experiment with PPX and is therefore to be interpreted with caution until 
replications have confirmed their external validity. 
 Of particular interest to the present study is the fact that Madden et al. (2010) used 
a fixed-delay procedure, investigating only a single LL delay for each subject in each of 
their two baseline conditions. Baseline conditions constrained nondrug preference to 
either low (≤ 20%) or high (≥ 80%) SS choice by titrating individual-subject LL delay 
values between conditions. Alternatively, Koffarnus et al. (2011) used an increasing-
delay procedure to examine intertemporal choice across a range of LL delays within each 
session. Concerns have been raised regarding the possibility of carry-over effects with 
increasing-delay procedures (Fox, Hand, & Reilly, 2008; Madden, Smith, Brewer, 
Pinkston, & Johnson, 2008). By definition, a carry-over effect implies that the effects of 
preceding trial blocks (i.e., shorter delays to LL reinforcers) influence choice in 
subsequent trial blocks, thereby inflating the measure of SS-LL preference in favor of the 
LL reinforcer. Suggestive of a carry-over effect, Koffarnus and others’ (2011) rats were 
approximately indifferent (i.e., 50% choice) between an immediate SS reinforcer and a 
larger reinforcer delivered following a 60-s delay whereas Diller, Saunders, and 
Anderson (2008), for example, showed that the same strain rarely chose a LL reinforcer 
when delayed by 16 s. To avoid or reduce the influence of carry-over effects in prior 
research using increasing-delay procedures, researchers have incorporated occasional 
“no-delay” sessions. In a no-delay session, the LL delay does not increment across trial 
blocks, in which case the subject should prefer the LL throughout the entire session. 
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Koffarnus et al. (2011) did not incorporate no-delay sessions into their experimental 
protocol and therefore may have increased the likelihood that preference was inflated. 
 Another procedural feature traditionally incorporated into nonhuman decision-
making protocols is the centering response. Prior to nonhumans choosing between 
concurrently available alternatives, “forced-choice” trials are typically programmed to 
expose the subject to the consequences of choosing either alternative in isolation. 
Following these trials, subjects are then required to choose between both alternatives in 
“free-choice” trials. In both trial types, the response alternatives are made available to the 
subject contingent upon a centering response. This procedural detail is included in an 
effort to discourage subjects from developing idiosyncratic biases in favor of one 
alternative. Choice trials in the procedure used by Koffarnus et al. (2011) were not 
preceded by a centering response, the absence of which may have encouraged biased 
choice, especially in sessions in which PPX was administered. The plausibility of PPX-
induced bias is bolstered by reports of perseverative responding following administration 
of the drug (Boulougouris et al., 2009; Haluk & Floresco, 2009). 
The present experiment systematically replicated the procedures of Koffarnus et 
al. (2011) by including these procedural control features. Intermittent no-delay sessions 
were scheduled to minimize the influence of carry-over effects, which could influence the 
PPX effect. A centering response also preceded all forced- and free-choice trials to 
reduce the likelihood of bias. In addition to replicating the acute procedures, the present 
experiment also evaluated the chronic effects of intermediate (0.1 mg/kg) and high (0.3 
mg/kg) PPX doses. This latter manipulation was conducted to address the concern that 
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clinical patients who develop ICDs administer PPX according to a chronic rather than an 
acute regimen, a difference that may distinguish human cases from nonhuman 
demonstrations. 
Methods 
Subjects 
Twelve experimentally naïve male Wistar rats served as subjects in the present 
experiment. Rats arrived in the colony weighing approximately 325-350 grams (~ 9 
weeks) and were housed individually in polycarbonate cages in a room maintained on a 
12/12 programmed light/dark cycle. With the exception of experimental sessions, which 
were conducted seven days per week, water was continuously available. At least two 
hours after each session, supplementary chow was provided in order to maintain weights 
of 375 grams. Animal use was in accordance with the Institutional Animal Care and Use 
Committee (IACUC) of the University of Kansas. 
Apparatus 
Sessions were conducted in standard operant conditioning chambers housed 
within sound-attenuating cubicles (Med Associates Inc., St. Albans, VT). Centered on the 
front wall of the chamber was a nonretractable lever with an accompanying stimulus 
lamp. Equidistant from each side of the center lever were left and right retractable side 
levers with stimulus lamps located above each lever. Located directly below the center 
lever was a food receptacle into which a pellet dispenser delivered 45 mg nutritional 
rodent pellets (Bio-Serv, Frenchtown, NJ). A houselight provided general illumination 
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except during the inter-trial interval (ITI). Chambers were also equipped with a white 
noise speaker and ventilation fan. All experimental events were coordinated and recorded 
via a PC in an adjacent room. 
Behavioral Procedure 
Lever pressing was initially trained using an autoshaping procedure. Once reliable 
responding was established, experimental sessions operated in similar respects to 
Evenden and Ryan (1996) and Koffarnus et al. (2011; i.e., increasing-delay procedure). 
Sessions were composed of 40 trials separated into four blocks of 10 trials each. Within 
each trial block, the first four trials were forced-choice trials followed by six free-choice 
trials. During forced-choice trials, only one lever was made available to ensure that 
subject experience the SS (1 food pellet) and LL (3 food pellets) reinforcers (two of each 
randomly). During free-choice trials, levers associated with SS and LL reinforcers were 
both made available, permitting choice between the two options. Prior to either forced- or 
free-choices, a signaled center-lever response was used to ensure the subject was 
equidistant from both side levers. Side levers were inserted following an effective center-
lever response (see Table 2-1 for LL lever assignment). If the SS was selected, both 
levers were retracted, stimulus lights were extinguished, and 1 food pellet was delivered 
to the food receptacle after 0.01 seconds (the minimum temporal resolution of the 
software). If the LL was selected, the same sequence was enacted, except that the 
stimulus light above the LL lever remained illuminated for the duration of the LL delay  
in effect. Once the LL delay had elapsed, three food pellets were delivered to the food 
receptacle. Failure to press the center or either side lever within 30 s of insertion ended 
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the trial and incremented an omission counter.  Following each reinforcer delivery 
sequence, the houselight was extinguished. A variable ITI ensured that trials began every 
100 seconds. 
 At the beginning of each session (i.e., first trial block), the SS and LL reinforcers 
were both available immediately (0.01 s). In each subsequent trial block, the LL delay 
increased by 10 s to produce LL delays of 10, 20 and 30 s. Separating each trial block 
was a 180-s blackout used to signal a change in LL delay. On a randomly selected day of 
the week, a regular session was replaced by a no-delay session. In a no-delay session, the 
LL reinforcer remained immediately available beyond the first trial block. 
Drug Procedure 
In order to begin the acute dosing assessment, rats’ percent LL choice had to meet 
quantitative stability criteria. First, at least 20 nondrug baseline sessions had to be 
conducted. Second, mean percent LL choice from the most recent 6 sessions could not 
differ by more than 10% from mean percent LL choice from the preceding 6 sessions in 
any trial block. Lastly, no omitted trials could occur during this same 12-session window. 
Once stability was achieved, saline or PPX (0.01, 0.03, 0.1, 0.18, and 0.3 mg/kg) 
was administered subcutaneously 10 minutes prior to every fifth session in a descending 
dose order beginning with saline. Two rats (G1R1 and P1R1) received only two 
administrations of 0.01 mg/kg as the decision to add this dose was made after their first 
dosing series had been completed. No-delay sessions occurred on the second day after 
each acute dose. The sequence of doses was assessed three times. 
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 Four days following completion of the acute dosing assessment subjects 
experienced chronic (i.e., daily) dosing with either saline or PPX (0.1 and 0.3 mg/kg) for 
at least 14 consecutive sessions. All subjects completed chronic dosing with 0.1 mg/kg 
first. A 12-day washout period separated the 0.1 mg/kg dosing period from a period of 
“chronic” saline administration. Following the saline assessment, rats were re-introduced 
to nondrug baseline conditions. Once quantitative stability was achieved, the chronic 0.3 
mg/kg dosing period was initiated. 
Data Analysis 
The primary dependent measure of interest was the percentage of choices for the 
LL reinforcer in each trial block. Percent LL choice data from no-delay sessions 
conducted during the acute assessment were evaluated in a one-way repeated-measures 
analysis of variance (ANOVA; IBM SPSS Statistics 20) with Trial Block as the single 
within-subject factor. For the acute dosing assessment, a two-way repeated-measures 
ANOVA was used to evaluate the Dose (saline, 0.01, 0.03, 0.1, 0.18, and 0.3 mg/kg) X 
Delay (0, 10, 20, and 30 s) effect. 
For the chronic dosing assessment, the mean percent LL choice for each trial 
block across the last 4 sessions was used in a two-way repeated-measures ANOVA (Dose 
X Delay). In the event that data failed to meet assumptions of sphericity, results were 
interpreted using Greenhouse-Geisser adjusted degrees of freedom. Significant 
interactions were decomposed with alpha-corrected one-way ANOVAs. All post-hoc 
pairwise comparisons used Bonferroni-corrected alpha criteria. Effect sizes were 
calculated as generalized eta squared (Bakeman, 2005). 
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Three rats (G1R3, G1R4, and P1R2) exhibited either hyper- or hyposensitivity to 
LL delays under nondrug baseline conditions. For these rats, PPX administration would 
have only been capable of shifting LL choice in one direction; on this basis these rats 
were excluded from the above analyses. Early in the course of the chronic PPX 
assessment, two rats (B1G1 and B1G2) fell ill and were euthanized; their data were 
excluded from chronic analyses. 
Results 
 Table 2-1 shows the number of sessions required for individual rats to meet 
stability criteria. On average, the acute dosing assessment began after approximately 45 
sessions (M = 45.67, SD = 8.74). Fewer sessions were required, on average, to initiate the 
0.3 mg/kg chronic assessment (M = 23.86, SD = 2.42). 
 Percent LL choice from no-delay sessions (data not shown) differed significantly 
across trial blocks, F(3, 24) = 6.25, p < .01, G
2 
= .44. Specifically, LL choice declined 
monotonically, significant linear contrast, F(1, 8) = 22.27, p < .01, G
2 
= .74. Only LL 
choice in the final trial block (M = 93.34, SD = 4.28) was significantly lower than LL 
choice in the first trial block (M = 98.95, SD = 1.21), p < .02. 
Acute PPX dose interacted significantly with the LL delay in effect, F(15, 120) = 
6.61, p < .001, G
2 
= .18 (Figure 2-1). Follow-up one-way ANOVAs with corrected 
alphas (p = 0.5/4 = .013) conducted at each LL delay revealed significant main effects of 
PPX dose in only the first trial block (0 s), F(2.21, 17.70) = 7.22, p < .01, G
2 
= .47. In 
the first trial block when both reinforcers were available immediately, acute PPX,  
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Table 2-1 
Lever Assignment of the LL Reinforcer and Sessions to Stability for Individual Rats in 
Acute and Chronic PPX Assessments 
  Sessions to stability 
Rat LL Lever Acute Chronic 
B1G1 Right 41 - 
B1G2 Left 50 - 
B1G3 Right 43 23 
B1G4 Left 41 23 
G1R1 Right 40 19
a
 
G1R2 Left 40 26 
P1R1 Right 43 27 
P1R3 Right 44 25 
P1R4 Left 69 24 
a
Did not complete minimum sessions for stability 
assessment due to experimenter error. 
 
especially at higher doses (top panel of Figure 2-1), produced visual decreases in LL 
choice from saline. Lower acute PPX doses (bottom panel of Figure 2-1) did not disrupt 
LL choice in this way. However, at no dose in the first trial block was choice affected to a 
degree as to differentiate it significantly from saline choice (all pairwise p’s > .15). 
Omissions occurred infrequently in the acute assessment and were affected by 
PPX dose, F(1.08, 8.61) = 5.74, p < .05, G
2 
= .42. These data are shown in Table 2-2, 
which displays individual-subject mean percent LL choice at each LL delay, as well as 
the mean number of omissions per session in this assessment. 
Figure 2-2 shows that chronic PPX also interacted significantly with LL delays, 
F(6, 36) = 5.83, p < .001, G
2 
= .17. This interaction was further investigated at each LL  
delay using one-way ANOVAs (p = .013). In only the fourth (30 s) trial block, F(2, 12) = 
16.74, p < .001, G
2 
= .74, chronic 0.3 mg/kg significantly increased LL choice above 
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Figure 2-1. Effects of acute PPX on LL choice as a function of LL delay. The top panel 
depicts doses that disrupted initial-block choice; shown in the bottom panel are doses that 
did not have this effect. Data are group means (±SEM). 
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Table 2-2 
Percent LL Choice at Each LL Delay and Omissions in the Acute PPX Assessment 
  LL delay (s)  
 
Rat 
PPX 
(mg/kg) 
 
0 
 
10 
 
20 
 
30 
Omissions 
per session 
B1G1 Saline 94.44  (4.54) 33.33   (7.86) 5.56   (4.54) 5.56   (4.54) 0.00 (0.00) 
 0.01 100.00  (0.00) 22.22   (4.53) 0.00   (0.00) 0.00   (0.00) 0.00 (0.00) 
 0.03 94.44  (4.54) 22.22   (9.07) 5.56   (4.54) 11.11   (4.54) 0.00 (0.00) 
 0.1 100.00  (0.00) 38.89   (4.54) 16.67   (7.86) 16.67   (7.86) 0.00 (0.00) 
 0.18 83.33  (7.86) 55.55 (12.00) 27.78 (16.36) 22.22   (9.07) 0.00 (0.00) 
 0.3 88.89  (9.07) 72.22 (12.00) 15.56 (19.77) 50.00   (7.86) 0.00 (0.00) 
       
B1G2 Saline 100.00  (0.00) 83.33   (7.86) 77.78 (18.15) 44.44 (19.77) 0.00 (0.00) 
 0.01 100.00  (0.00) 100.00   (0.00) 77.78   (4.53) 66.67   (0.00) 0.00 (0.00) 
 0.03 100.00  (0.00) 94.44   (4.54) 38.89   (4.54) 38.89   (9.07) 0.00 (0.00) 
 0.1 88.89  (4.54) 55.56   (9.07) 44.44   (9.07) 44.44 (19.77) 0.00 (0.00) 
 0.18 77.78  (9.07) 50.00 (20.79) 66.66 (13.61) 55.56 (16.35) 0.33 (0.27) 
 0.3 66.67  (7.86) 67.78 (19.90) 50.00 (20.79) 27.78   (4.53) 1.00 (0.82) 
       
B1G3 Saline 100.00  (0.00) 94.44   (4.54) 33.33   (7.86) 11.11   (4.54) 0.00 (0.00) 
 0.01 100.00  (0.00) 61.11   (4.54) 22.22 (12.00) 0.00   (0.00) 0.00 (0.00) 
 0.03  94.44  (4.54) 55.56   (4.54) 22.22 (12.00) 16.67 (13.61) 0.00 (0.00) 
 0.1 100.00  (0.00) 38.89 (12.00) 55.55 (12.00) 33.33   (7.86) 0.00 (0.00) 
 0.18 100.00  (0.00) 66.67   (7.86) 33.34 (13.61) 44.44 (19.77) 0.00 (0.00) 
 0.3 94.44  (4.54) 88.89   (4.54) 83.33   (7.86) 77.78   (9.07) 4.33 (3.54) 
       
B1G4 Saline 100.00   (0.00) 94.44   (4.54) 77.78 (12.00) 33.33 (15.71) 0.00 (0.00) 
 0.01 100.00   (0.00) 61.11 (12.00) 33.33 (15.71) 5.56   (4.54) 0.00 (0.00) 
 0.03 100.00   (0.00) 61.11 (18.14) 22.22   (4.53) 5.56   (4.54) 0.00 (0.00) 
 0.1   66.67 (15.71) 61.11   (9.07) 38.89   (9.07) 16.67   (0.00) 0.00 (0.00) 
 0.18 55.55 (12.00) 66.66 (13.61) 22.22   (4.53) 27.78   (4.53) 0.00 (0.00) 
 0.3 33.34 (13.61) 11.11   (9.07) 50.00   (7.86) 33.33   (7.86) 0.00 (0.00) 
       
G1R1 Saline 100.00   (0.00) 55.56   (9.07) 50.00 (13.61) 16.67   (7.86) 0.00 (0.00) 
 0.01
a
 100.00   (0.00) 66.67 (11.78) 0.00   (0.00) 0.00   (0.00) 0.00 (0.00) 
 0.03 88.89   (9.07) 22.22 (12.00) 5.56   (4.54) 11.11   (4.54) 0.00 (0.00) 
 0.1 61.11 (12.00) 47.78 (12.80) 22.22   (4.53) 22.22 (12.00) 0.33 (0.27) 
 0.18 83.33   (0.00) 55.56 (16.35) 22.22 (12.00) 33.33   (7.86) 1.33 (1.09) 
 0.3 77.78   (4.53) 44.44   (9.07) 52.22   (6.35) 33.33 (13.61) 0.67 (0.27) 
       
G1R2 Saline 100.00   (0.00) 72.22 (12.00) 44.44 (16.35) 16.67   (7.86) 0.00 (0.00) 
 0.01 94.44   (4.54) 61.11   (4.54) 38.89 (12.00) 33.33   (7.86) 0.00 (0.00) 
 0.03 100.00   (0.00) 88.89   (4.54) 50.00 (15.71) 16.67   (7.86) 0.00 (0.00) 
 
(table continues) 
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  LL delay (s)  
 
Rat 
PPX 
(mg/kg) 
 
0 
 
10 
 
20 
 
30 
Omissions 
per session 
 0.1 66.67 (27.22) 44.45 (18.15) 33.33 (15.71) 44.44 (24.00) 0.00 (0.00) 
 0.18 83.33   (7.86) 72.22 (12.00) 38.89   (4.54) 44.44   (4.54) 0.00 (0.00) 
 0.3 83.33   (7.86) 44.44 (24.00) 16.67   (7.86) 11.11   (9.07) 2.00 (1.63) 
       
P1R1 Saline 100.00   (0.00) 61.11   (4.54) 11.11   (4.54) 0.00   (0.00) 0.00 (0.00) 
 0.01
a
 100.00   (0.00) 75.00   (5.89) 33.34 (23.57) 16.67 (11.78) 0.00 (0.00) 
 0.03 100.00   (0.00) 55.55 (12.00) 27.78   (9.07) 33.33   (7.86) 0.00 (0.00) 
 0.1 94.44   (4.54) 61.11 (18.14) 33.33   (0.00) 5.56   (4.54) 0.33 (0.27) 
 0.18 88.89   (4.54) 83.33   (7.86) 55.56 (19.77) 44.44 (24.00) 0.33 (0.27) 
 0.3 91.67   (6.80) 81.11   (9.47) 61.11 (25.26) 50.00 (14.14) 4.67 (1.91) 
       
P1R3 Saline 100.00   (0.00) 77.78   (9.07) 63.33 (15.15) 27.78   (4.53) 0.33 (0.27) 
 0.01 100.00   (0.00) 77.78   (4.53) 44.44 (24.00) 27.78 (16.36) 2.67 (2.18) 
 0.03 100.00   (0.00) 77.78   (4.53) 27.78   (9.07) 44.44 (19.77) 0.00 (0.00) 
 0.1 87.78   (5.05) 55.56   (4.54) 37.78 (17.24) 27.78   (4.53) 1.67 (0.98) 
 0.18 88.89   (4.54) 77.78   (4.53) 64.45   (1.82) 53.89 (13.97) 1.33 (0.54) 
 0.3 93.33   (5.44) 86.11   (6.00) 53.33   (8.32) 83.33   (7.86) 10.33 (2.37) 
       
P1R4 Saline 100.00   (0.00) 100.00   (0.00) 50.00 (15.71) 27.78 (12.00) 0.00 (0.00) 
 0.01 100.00   (0.00) 88.89   (4.54) 55.56   (4.54) 33.34 (13.61) 0.33 (0.27) 
 0.03 100.00   (0.00) 77.78   (4.53) 50.00   (0.00) 11.11   (4.54) 0.33 (0.27) 
 0.1 100.00   (0.00) 72.22 (12.00) 55.56   (4.54) 50.00 (13.61) 0.00 (0.00) 
 0.18 100.00   (0.00) 94.44   (4.54) 55.56   (4.54) 44.44   (4.54) 0.33 (0.27) 
 0.3 61.11 (18.14) 73.33 (21.77) 72.22 (12.00) 44.45 (18.15) 1.33 (1.09) 
Note. Standard error of the mean of three administrations per dose is in parentheses. 
a
 Only two administrations. 
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Figure 2-2. Effects of chronic PPX on LL choice as a function of LL delay. Data are 
group means (±SEM). 
 
both saline and chronic 0.1 mg/kg levels. 
Chronic PPX administration resulted in infrequent omissions and did not reduce 
their occurrence below the rate observed in the acute assessment (p > .25). Table 2-3 
displays individual-subject mean percent LL choice at each LL delay and mean omissions 
per session over the final four sessions of the chronic assessment. 
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Table 2-3 
Percent LL Choice at Each LL Delay and Omissions in the Chronic PPX Assessment  
  LL delay (s)  
 
Rat 
PPX 
(mg/kg) 
 
0 
 
10 
 
20 
 
30 
Omissions 
per session 
B1G3 Saline 100.00 (0.00) 62.50 (12.33) 16.67 (10.21) 4.17   (3.61) 0.00 (0.00) 
 0.1 100.00 (0.00) 66.67   (5.89) 37.50   (6.91) 41.67   (9.32) 0.00 (0.00) 
 0.3 100.00 (0.00) 75.00   (4.17) 58.33   (9.32) 62.50   (3.61) 0.75 (0.42) 
       
B1G4 Saline 100.00 (0.00) 95.24   (4.17) 66.67   (8.33) 20.83   (6.91) 0.00 (0.00) 
 0.1 100.00 (0.00) 62.50 (12.33) 25.00   (9.32) 16.67   (8.33) 0.00 (0.00) 
 0.3 100.00 (0.00) 79.17 (10.83) 75.00   (7.22) 58.33   (9.32) 0.00 (0.00) 
       
G1R1 Saline 100.00 (0.00) 36.11   (8.89) 2.78   (3.11) 5.56   (3.93) 0.00 (0.00) 
 0.1 100.00 (0.00) 20.83 (10.83) 12.50   (3.61) 8.33   (7.22) 0.00 (0.00) 
 0.3 91.67 (7.22) 91.67   (4.17) 54.17 (18.04) 35.42 (13.94) 1.00 (0.35) 
       
G1R2 Saline 100.00 (0.00) 95.83   (3.61) 58.33   (7.22) 50.00   (5.89) 0.00 (0.00) 
 0.1 100.00 (0.00) 87.50   (6.91) 87.50   (6.91) 62.50   (3.61) 0.00 (0.00) 
 0.3 100.00 (0.00) 95.83   (3.61) 100.00   (0.00) 70.84   (3.61) 0.00 (0.00) 
       
P1R1 Saline 100.00 (0.00) 75.00   (9.32) 20.84   (9.08) 25.00   (7.22) 0.00 (0.00) 
 0.1 100.00 (0.00) 62.50   (3.61) 29.17   (6.91) 16.67   (0.00) 0.00 (0.00) 
 0.3 100.00 (0.00) 87.50   (6.91) 37.50 (13.66) 54.17   (9.08) 0.00 (0.00) 
       
P1R3 Saline 100.00 (0.00) 100.00   (0.00) 83.33 (10.21) 37.50   (6.91) 0.00 (0.00) 
 0.1 100.00 (0.00) 54.17   (3.61) 58.33   (9.32) 25.00   (7.22) 0.00 (0.00) 
 0.3 91.11 (3.66) 100.00   (0.00) 89.58   (5.41) 42.50   (8.77) 7.17 (2.20) 
       
P1R4 Saline 100.00 (0.00) 75.00   (9.32) 50.00 (15.59) 58.33   (9.32) 0.00 (0.00) 
 0.1 100.00 (0.00) 91.67   (7.22) 91.67   (4.17) 70.84   (9.08) 0.00 (0.00) 
 0.3 95.83 (3.60) 100.00   (0.00) 90.83   (4.62) 95.83   (3.61) 5.75 (1.08) 
Note. Standard error of the mean of the final four administrations per dose is in 
parentheses. 
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Discussion 
 The present experiment attempted to systematically replicate the within-session 
increasing-delay procedures used by Koffarnus et al. (2011) to investigate the effects of 
acute PPX on intertemporal choice. Intermittent no-delay sessions, in which the LL delay 
did not increment across trial blocks, and a centering response requirement were included 
to address potential concerns regarding the influence of carry-over effects and the 
development of response biases, respectively. Along with these procedural modifications, 
the present experiment also assessed PPX’s effects on intertemporal choice when the 
drug was administered chronically before sessions. Results of relevance to the research 
conducted by Koffarnus et al. (2011), as well as to previous attempts to investigate the 
drug effect on nonhuman intertemporal choice (Madden et al., 2010) will be discussed 
and interpreted in turn. 
 A primary rationale for conducting the present experiment was the inclusion of 
certain procedural details omitted by Koffarnus et al. (2011), the absence of which may 
have affected the form of the drug effect. First, no-delay sessions were occasionally 
substituted for normal sessions (i.e., increasing-delay) in the present experiment to 
encourage rats to discriminate the presence/absence of a LL delay prior to choice 
opportunities. If rats’ choice for the LL reinforcer declined during no-delay sessions, as 
was characteristic of normal sessions in which LL delays were present, then concerns 
regarding carry-over effects or habitually inflexible choice may be warranted. Although 
LL reinforcer choice declined slightly across trial blocks, there was little evidence to 
suggest that carry-over effects influenced the present findings. Second, prior to insertion 
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of the side levers corresponding to the choice alternatives, rats were required to emit a 
centering response. In principle, this procedural detail should discourage the development 
of lever biases or response perseveration resulting from PPX administration (e.g., 
Boulougouris et al., 2009; Haluk & Floresco, 2009). However, because there were no 
trials in which the centering response was not required, it is difficult to conclude that this 
manipulation was effective at deterring bias or reducing the likelihood of perseverative 
responding. 
 With respect to the findings of Koffarnus et al. (2011), the present experiment 
reproduced shifts in rats’ intertemporal choice produced by administration of low (0.01-
0.03 mg/kg) and high (0.1-0.3 mg/kg) acute PPX doses. At the highest dose investigated 
(0.32 mg/kg), Koffarnus et al. (2011) observed an across-block decrease in choice for the 
LL reinforcer, including the initial trial block in which both reinforcers were available 
immediately. Similar changes in the form of the preference function were observed at 
higher doses (0.1-0.3 mg/kg) in the present experiment. Koffarnus et al. (2011) did not 
report any effects of lower PPX doses (0.032 and 0.1 mg/kg). The present experiment 
also found no effect of lower PPX doses (0.01 and 0.03 mg/kg), although the group 
preference function shifted toward indifference (i.e., 50% choice) at the 0.1 mg/kg PPX 
dose, which did not occur in the Koffarnus et al. (2011) study. Despite these formal 
changes–some of which contributed to the interaction between PPX dose and LL delay–
further investigation at each LL delay revealed that only LL choice in the first trial block 
(0 s) was significantly affected by the drug following alpha corrections. In interpreting 
the apparent lack of drug effect, the variability of LL choice at the individual subject 
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level should be considered. Standard errors of the mean, for example, increased dose-
dependently, F(1, 8) = 14.71, p < .01, G
2 
= .29, as well as delay-dependently, F(1, 8) = 
13.54, p < .01, G
2 
= .32 (significant linear contrasts). By increasing sample sizes, future 
researchers may proactively improve the likelihood of detecting significant acute PPX-
induced changes in intertemporal choice. 
 Rats also received PPX chronically (0.1 and 0.3 mg/kg for 14 consecutive 
sessions each), a regimen more closely approximating the manner in which clinical 
populations administer the drug and other DA agonist medications. As in the acute 
assessment, chronic PPX dose interacted with the LL delay in effect. Compared to the 
form of the preference functions generated with acute administration of these same doses, 
the form of the chronic preference functions differed in that the decrease in LL reinforcer 
choice in the initial trial block observed with acute PPX was not observed. More 
generally, restoration of near-exclusive LL reinforcer choice in this trial block was 
accompanied by an across-block upward shift in LL reinforcer choice relative to the acute 
functions. This increase was most pronounced in the final trial block (30 s), at which LL 
choice was significantly affected by the 0.3 mg/kg dose. Thus, in addition to restoring 
initial block choice for the LL reinforcer, PPX increased rats’ choice for the LL 
reinforcer at a single dose. 
 Despite reproducing the findings of Koffarnus et al. (2011), the present data are in 
contrast to the report of increased SS choice following acute PPX administration by 
Madden et al. (2010). In both Koffarnus et al. (2011) and the present work, higher PPX 
doses disrupted rats’ choice for a larger food reinforcer (3 pellets) over smaller food 
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reinforcer (1 pellet) in the absence of delays to reinforcement (i.e., sensitivity to relative 
reinforcer amount). Koffarnus et al. (2011) also observed concomitant flattening of the 
preference function (i.e., reduced effect of LL delay) at the highest PPX dose 
investigated. The preference functions produced herein also exhibited a tendency toward 
a reduced effect of LL delay as PPX dose increased. Consistent with this trend, PPX 
tended to increase LL choice above saline levels in the final trial block (30 s). 
Collectively, the directions in which LL choice was shifted provide suggestive evidence 
that the drug at least partially impaired stimulus control over choice behavior. By 
contrast, the procedure used by Madden et al. (2010) was designed specifically to address 
the possibility that PPX had such an effect. Essentially, a control condition in which rats 
predominantly chose the SS reinforcer on more than 80% of trials provided the 
experimenters the opportunity to observe PPX-induced decreases in SS choice. Coupled 
with the PPX-induced increases in SS choice observed in the opposite baseline condition 
(≤ 20% SS choice), decreased SS choice would indicate that, rather than simply 
increasing SS choice specifically, PPX may disrupt stimulus control over choice behavior 
and promote indifference between the two alternatives. Such a decrease in the control 
condition was not observed, suggesting that the PPX effect in the opposite baseline was 
likely not due to nonspecific drug effects such as poor stimulus control. 
To reconcile these divergent findings, it is worth considering that although both 
procedures–fixed-delay and increasing-delay–are designed to provide researchers with 
steady-state baseline indices of intertemporal choice, the manner in which drugs interact 
with static and dynamic decision-making performances remains relatively unknown. 
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Comparatively, the fixed-delay procedure requires only that subjects discriminate a single 
intertemporal choice throughout each session while the increasing-delay procedure 
requires successive discriminations of LL delays as this variable is incremented within 
the session. Drug administration in such a dynamic environment may increase the 
likelihood that independent variables are rendered less consequential and that choice 
trends toward indifference between the two alternatives. This procedural analysis may 
explain in part the complex behavioral effects of PPX in the present experiment, namely 
the diminished effect of LL delay on choice with increasing acute and chronic doses. 
Additional research, however, is required to further elucidate the behavioral processes 
underlying PPX-induced impulsivity and whether the mechanisms responsible for 
changes in intertemporal choice are generally applicable to clinical ICDs. 
A few shortcomings of the present experiment deserve comment. First, although 
replication of the procedures used by Koffarnus et al. (2011) was a primary objective, the 
findings of Madden et al. (2010) also represent an isolated report in need of replication. 
Previous experiments using the fixed-delay procedure suggest the preparation generates 
baseline performances that are sensitive to PPX manipulations of gambling-like behavior 
(Johnson et al., 2011; Johnson et al., 2012). Beyond these three experiments, however, 
there are no reported attempts to further validate the fixed-delay procedure, from which 
researchers interested in PPX and intertemporal choice would likely benefit. Second, 
PPX was not administered prior to no-delay sessions. Impairments in no-delay sessions 
could be useful in determining whether choice is globally disrupted regardless of the 
presence or absence of delays or if disruptions observed in the present experiment are 
   
 
 
  51 
  
specific to choices involving delay to reinforcement. Finally, while not obviously 
problematic in the interpretation of the findings, subject attrition did occur, especially 
between the acute and chronic assessments. The within-subjects design was preferable in 
that intrasubject variability was minimized (Sidman, 1960). Although a comparable 
sample size to the one in the present experiment was used by Koffarnus et al. (2011; n = 
12), researchers attempting to replicate the present experiment may choose a larger 
sample size in an effort to reduce this variability further and increase one’s ability to 
detect significant differences between PPX doses. 
In a systematic replication of Koffarnus et al. (2011), acute and chronic PPX 
administration altered rats’ choice for a LL reinforcer as its delay increased across blocks 
of trials. In both assessments, the effect of LL delay on choice was reduced in drug 
sessions (i.e., preference functions became increasingly shallow relative to saline) and, in 
the chronic assessment, acute disruptions in choice for larger over smaller food 
reinforcement were remediated. Compared to the findings of Madden et al. (2010), the 
present results suggest that PPX may nonspecifically impair aspects of stimulus control 
rather than simply increasing SS choice. Specifying the drug’s effects on behavioral 
processes involved in complex performances such as intertemporal choice may yet reveal 
a unifying framework for understanding the mechanisms responsible for PPX-induced 
impulsivity. 
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CHAPTER 3 
BEHAVIORAL MECHANISMS OF PRAMIPEXOLE-INDUCED 
IMPULSIVITY 
Abstract 
 The effects of pharmacological variables on complex operant behavior can be 
understood through the investigation of behavioral mechanisms of drug action. 
Pramipexole (PPX), a D2/D3 dopamine (DA) receptor agonist, is associated with 
increased rates of impulsive behavior in clinical populations prescribed the drug as well 
as in nonhumans (rats) administered PPX prior to making intertemporal choices. 
Experiments in the latter category have produced divergent findings and require further 
explication. Madden et al. (2010) reported increased choice for a “smaller-sooner” (SS) 
reward in rats with PPX administration, while Koffarnus et al. (2011) and the experiment 
presented in Chapter 2 suggested that similar doses of the drug may nonspecifically 
impair stimulus control of choice behavior. Across three experiments, the present study 
attempted to elucidate the contributions of behavioral processes recruited during 
intertemporal choice and potentially affected by PPX administration in a manner likely to 
produce the pattern of results observed in prior research. Experiment 1 evaluated rats’ 
sensitivity to relative reinforcer delays in a concurrent-chains preparation following acute 
(0.03-0.3 mg/kg) and chronic (0.18 mg/kg) PPX administration. Acute PPX decreased 
sensitivity to relative reinforcer delay, an outcome inconsistent with the interpretation of 
previous findings. Experiment 2 examined an alternative explanation for the findings of 
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Experiment 1 and previous studies, namely that PPX impairs the accuracy with which 
rats discriminated response-reinforcer contingencies. Chronic PPX (0.18 mg/kg) reduced 
accuracy of this discrimination in a symbolic matching-to-sample task. Experiment 3 
investigated the effects of the same chronic PPX dose on rats’ discrimination of different 
reinforcer amounts (1 vs. 3 pellets). In similar respect to Experiment 2, PPX reduced the 
accuracy of amount discrimination. As noted in Chapter 2, impaired amount 
discrimination in an intertemporal choice can increase SS choice by reducing the 
influence of amount differences on choice. Whether PPX effects elucidated in contrived 
procedures are operative in intertemporal choice experiments or clinical instances of 
impulsive behavior is presently unknown and remains an area of emphasis for future 
research. 
Introduction 
 Beginning with the inception of their field of study, behavioral pharmacologists 
have sought to describe and elucidate the effects of pharmacological variables on 
acquisition (i.e., learning) and maintenance of behavioral performances. Initial efforts 
were focused largely on the systematic evaluation of drug classes (e.g., stimulants) 
applied to aversively- and positively-motivated operant behaviors, typically lever 
pressing in rats or key pecking in pigeons under simple schedules of reinforcement (e.g., 
fixed-interval; Boren, 1961; Clark & Steele, 1966; Cook & Kelleher, 1962; Dews, 1958; 
Gollub & Brady, 1965; Kelleher, Fry, Deegan, & Cook, 1961; Weiss & Laties, 1964). 
Drug-induced changes in rate or topography of responding were of primary interest and 
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served to underscore the dependency of complex drug-behavior interactions upon 
environmental variables. 
Subsequent approaches to behavioral pharmacology have since promoted the 
identification of behavioral mechanisms of drug action (Branch, 1984, 1991; Thompson 
& Schuster, 1968). Such an approach requires that, prior to the assessment of drug 
effects, the functional relations between behavior and environmental variables that 
support its occurrence under nondrug conditions are specified. This information in hand, 
researchers are then equipped to interpret the particular action of a drug in terms of a 
change in a behavioral process, that is, the manner in which behavior is influenced by a 
particular environmental variable. A change in a behavioral process therefore constitutes 
a potential behavioral mechanism of drug action. 
Applied to complex behavioral performances such as impulsive decision-making, 
the utility of this analytic strategy is realized in the isolation of behavioral processes 
germane to the phenomenon of interest and the observation of drug-induced changes in 
these processes consistent with clinically relevant behavioral problems. For instance, 
pramipexole (PPX), a D2/D3 dopamine (DA) agonist prescribed in the treatment of 
Parkinson’s disease, restless legs syndrome, fibromyalgia and treatment-resistant 
depression has been associated with the development of a range of impulse control 
disordered behaviors (ICDs). Documented ICDs include pathological gambling (e.g., 
Dodd et al., 2005, Driver-Dunckley et al., 2003), hypersexuality (e.g., Giladi et al., 2007; 
Klos et al., 2005), and compulsive eating (Hassan et al., 2011) or shopping (Cornelius et 
al., 2010). Although the exact etiology of ICDs remains unknown, their manifestation is 
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coincident with initiation of PPX or other DA agonist regimens; ICDs typically cease 
following decreases in agonist dosage or termination of the regimen (Avila et al., 2011; 
Mamikonyan et al., 2008). Assuming that PPX and other DA agonists affect functional 
relations between the expression of ICDs and variables in the clinical environment which 
either support or discourage this class of impulsive behavior, an experimental analysis of 
behavioral mechanisms underlying these drug effects is warranted. 
The search for candidate behavioral mechanisms of PPX-induced impulsivity has 
also been instigated by findings that the drug affects intertemporal choice in nonhumans. 
Madden et al. (2010) observed that PPX (0.1-0.3 mg/kg) increased the frequency of rats’ 
choice of a smaller, sooner (SS) reinforcer (1 food pellet) when administered in a 
condition in which nondrug choice favored a larger, later (LL) reinforcer (3 pellets 
delivered after a delay). In a separate condition of nondrug SS preference, PPX did not 
affect rats’ choice for this alternative; the results of this control condition suggested that 
PPX-related increases in SS choice were not the product of nonspecific disruption of 
choice (e.g., impairment of stimulus control). Using an increasing-delay procedure 
(Evenden & Ryan, 1996), Koffarnus et al. (2011) also assessed the effects of PPX on 
intertemporal choice. Only one PPX dose (0.32 mg/kg), however, increased the 
frequency of SS choice above saline levels and did so in a manner suggestive of 
nonspecific disruption of choice when both reinforcers were available immediately (1 vs. 
3 sucrose pellets). The experiment presented in Chapter 2 systematically replicated the 
procedures of Koffarnus et al. (2011) and reproduced this disruption induced by higher 
PPX doses (0.1-0.3 mg/kg). 
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These mixed findings raise two questions. First, which behavioral mechanisms 
contribute to instances of PPX-induced impulsivity as observed by Madden et al. (2010)? 
Second, are the same behavioral mechanisms equally likely to contribute to instances of 
PPX-induced disruption of choice as observed by Koffarnus et al. (2011) and 
systematically replicated in Chapter 2? The first mechanism by which PPX could 
increase impulsive choice is by enhancing sensitivity to relative reinforcer delay across 
concurrently available alternatives. As noted in Chapter 1, if PPX increases sensitivity to 
relative reinforcer delay, this would increase preference for SS reinforcers.  
Two other behavioral processes might be affected by PPX and these were 
explored in Experiment 2 and 3 after it was learned that sensitivity to relative reinforcer 
delays was decreased by PPX. Experiment 2 assessed the effects of chronic PPX on rats’ 
discrimination of response-reinforcer contingencies using a symbolic matching-to-sample 
(SMTS) procedure. Specifically, rats were required to report which of two responses–left 
or right lever press–produced a food pellet on a given trial. Reduced accuracy of this 
discrimination following PPX administration might provide an alternative explanation for 
the results of Experiment 1, namely that rats were less able to discriminate which 
response produced the reinforcer in the concurrent-chains procedure. In terms of response 
allocation, imperfect discrimination of response-reinforcer contingencies would be 
expected to produce more equally-distributed responding and shallower-sloped matching 
functions. The SMTS procedure was modified slightly for Experiment 3 to assess the 
drug’s effects on rats’ discrimination of small (1 pellet) and large (3 pellets) food 
amounts. These two discrimination processes were targeted for investigation as PPX-
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induced disruptions in their integrity were hypothesized to increase the likelihood of SS 
choice in intertemporal choice situations. 
Experiment 1 
Introduction 
One of the limitations of discrete-choice procedures used to investigate PPX’s 
effects on intertemporal choice is the inability to dissociate the contributions of individual 
behavioral processes to complex decision-making performances. In large part, this is due 
to the choice structure, which concurrently arranges differences in amount and delay. 
Consequently, if PPX affects preference in a discrete-choice procedure, it is difficult–if 
not impossible–to specify the behavioral mechanism or mechanisms responsible for the 
drug effect. 
 Further inspection of the behavioral processes thought to underlie PPX’s effects 
on intertemporal choice can, however, be carried out by coupling a concurrent-chains 
preparation with the analytical logic of Equation 8. Rather than presenting the organism 
with an intertemporal choice, one reinforcement parameter (e.g., differences in amount) 
can be equalized, leaving the remaining reinforcement parameter (e.g., differences in 
reinforcer delay) to determine response allocation. Sensitivity to the isolated parameter, a 
putative behavioral process, can then be characterized quantitatively as the slope of 
Equation 4. Against a saline baseline, changes in the behavioral process of interest (e.g., 
sensitivity to relative reinforcer delays or reinforcer amounts) following PPX 
administration constitute a potential behavioral mechanism of PPX-induced impulsivity. 
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 In concert with the predictions of Equation 8, the increase in SS choice observed 
by Madden et al. (2010) could have been due to an increase in sensitivity to relative 
reinforcer delay (see Fig. 1-3) or a decrease in sensitivity to relative reinforcer amount 
(see Fig. 1-4). Using a concurrent-chains procedure and the analytical logic outlined 
above, changes in these behavioral processes can be described as changes in the slope of 
the matching function. In the case of increased delay sensitivity, the steeper-sloped 
matching function expected following PPX administration is easily interpreted. With 
respect to decreased amount sensitivity, however, one cannot confidently deduce that a 
shallower matching function produced by PPX is the result of said behavioral 
mechanism. An alternative explanation for a shallower slope could be that PPX impaired 
stimulus control, rendering the two alternatives generally less discriminable regardless of 
sensitivity to relative reinforcer amounts. This latter effect, albeit undesirable in the 
context of a concurrent-chains preparation, may provide evidence in support of the 
interpretations of Koffarnus et al. (2011) and Chapter 2, namely that PPX administration 
may disrupt aspects of stimulus control. 
In an effort to distinguish between these interpretations, Experiment 1 evaluated 
the acute and chronic PPX effect on sensitivity to relative reinforcer delay in a 
concurrent-chains preparation. On one hand, if PPX increased sensitivity to relative 
reinforcer delay, as might have been the case in Madden et al. (2010), the slope of the 
matching function produced with PPX was predicted to be greater than the slope of the 
nondrug (i.e., saline) matching function. On the other hand, if PPX nonspecifically 
disrupted choice by impairing stimulus control, as might have been the case in Koffarnus 
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et al. (2011) and Chapter 2, the slope of the matching function was predicted to be lesser 
than the slope of the nondrug matching function. A trend toward equalized response 
allocation observed as a relatively shallow function might therefore signal that 
differences in the independent variable (i.e., terminal-link delays to reinforcement) were 
inconsequential due to poor discrimination of features of the choice alternatives. 
Methods 
Subjects. Twelve experimentally naïve male Wistar rats served as subjects. Rats 
arrived in the colony weighing approximately 325-350 grams (~ 9 weeks) and were 
housed individually in polycarbonate cages in a room maintained on a 12/12 programmed 
light/dark cycle. With the exception of experimental sessions, which were conducted 7 
days per week, water was continuously available. At least 2 hours after each session, 
supplementary chow was provided in order to maintain weights of 375 grams. 
All rats having completed the acute assessment served as subjects in the chronic 
assessment (n = 11, see below). With the exception of the drug administration regimen, 
all environmental conditions–experimental and extra-experimental–were identical across 
assessments. Animal use was in accordance with the Institutional Animal Care and Use 
Committee (IACUC) of the University of Kansas. 
Apparatus. Experimental sessions were conducted in six identical operant 
conditioning chambers (24.1 cm x 30.5 cm x 21.0 cm; Med Associates Inc., St. Albans, 
VT). The intelligence panel of each chamber featured two low-profile, retractable side 
levers (ENV-112CM, Med Associates Inc.) spaced horizontally 11 cm apart. A 28-volt 
DC cue light was located 6 cm above each lever. Positioned 1 cm above the floor and 
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centered between the side levers was a pellet receptacle into which nutritional grain-
based rodent pellets could be delivered (45 mg; Bio-Serv, Frenchtown, NJ). A speaker 
generated white noise to mask extraneous sound and a fan ventilated the sound-
attenuating cubicle in which each chamber was located. Experimental sessions were 
executed by a PC running MED-PC® IV software in an adjacent room. 
Behavioral procedure. Lever pressing was initially trained using an autoshaping 
procedure. Once reliable responding had been established, a concurrent-chains procedure 
was introduced for 40-trial sessions (see Pitts & Febbo, 2004). Each trial began with both 
levers inserted into the chamber and the stimulus light above each lever lit. During the 
initial link of the concurrent-chains schedules, dependent VI 30-s schedules (Stubbs & 
Pliskoff, 1969) were programmed according to two separate distributions (Fleshler & 
Hoffman, 1962). On each trial, the left or right lever randomly granted terminal-link 
access with two restrictions: (a) The same lever could not produce terminal-link access 
on more than 3 consecutive trials, and (b) left and right levers were selected an equal 
number of times per session (20 each). A 3-s changeover delay (COD) was programmed; 
responses emitted during the COD could not produce terminal-link access. 
When a lever press granted terminal-link access, the levers were retracted, the 
stimulus light above the unselected lever was extinguished, and a delay to reinforcement 
was initiated. The duration of the terminal-link delay depended upon the lever selected 
and the experimental condition (see below). After the terminal-link delay, two food 
pellets were delivered to the receptacle regardless of which alternative produced 
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terminal-link access. Trials ended with an ITI in which all stimuli were off; the ITI 
duration was adjusted so that trials started every 100 s. 
Response allocation was investigated in three conditions in which the terminal-
link delays were manipulated. In the first condition, both terminal-link delays were 7.5 s 
(equal delay condition). In subsequent conditions, left/right terminal-link delays were 12 
s/3 s and 3 s/12 s; the order in which rats experienced these unequal delay conditions was 
counterbalanced across subjects (Table 3-1). 
Baseline (no-injection) sessions continued in each condition for at least 20 
sessions and until (a) the mean initial-link response proportion (left/total) from the last 
three sessions deviated by < .05 from the mean of the previous three sessions, and (b) no 
monotonic trend was visually apparent over the last six sessions. After response 
allocation met these stability criteria, the acute dosing assessment began. 
Drug procedure. PPX hydrochloride (N’-propyl-4,5,6,7-tetrahydrobenzothiazole-
2,6-diamine dihydrochloride) was synthesized and provided by Drs. Shaomeng Wang and 
Jianyong Chen (University of Michigan, Ann Arbor, MI). PPX was dissolved in 
physiological saline (0.9% NaCl) and was administered subcutaneously at a volume of 
1.0 ml/kg. 
Ten minutes prior to every fifth session, saline or PPX (0.03, 0.1, 0.18, and 0.3 
mg/kg) was administered subcutaneously in a descending dose order beginning with 
saline. The sequence of doses was assessed twice in each delay condition. 
 Following completion of the acute dosing assessment and a 4-day washout period, 
subjects experienced chronic (i.e., daily) dosing with either saline or PPX (0.18 mg/kg) 
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for at least 14 consecutive sessions in an order counterbalanced across subjects. Four-day 
washout periods separated each chronic regimen. The order of delay conditions 
experienced in the chronic assessment was opposite that of the order experienced in the 
acute assessment with stability reassessed for each condition.  
Data analysis. For both acute and chronic dosing assessments, the logarithm of 
the response allocation ratio for each dose was plotted as a function of the logarithm of 
the terminal-link delay ratio in each experimental condition. For the acute assessment, 
linear regressions were performed on the geometric means from the two dosing series. 
Because reinforcer amounts were equivalent across alternatives, Equation 8 could be 
reduced to a version in which response allocation (log[R1/R2]) is determined exclusively 
by the ratio of reinforcer delays: 
        
  
  
        
     
     
      .      (9) 
Equation 9 was used to estimate sensitivity to relative reinforcer delay (d) and bias (log 
b) for the acute assessment; these parameters were estimated for the chronic assessment 
using the final 6 sessions of the chronic assessment. To quantitatively isolate changes in d 
from PPX-induced changes in the rate of delay discounting (k), model fits assumed a 
constant k of 1 (see Pitts & Febbo, 2004). Parameters were analyzed using a one-way 
repeated-measures ANOVA with Dose (saline, 0.03, 0.1, 0.18, and 0.3 mg/kg) as the only 
within-subject factor. 
Because reports of D2/D3 DA agonist-induced response perseveration are not 
uncommon (Boulougouris et al., 2009; Haluk & Floresco, 2009), the effects of PPX on 
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average bout length (i.e., number of responses preceding a changeover event) was 
evaluated using a two-way, repeated-measures ANOVA (Delay Condition, Dose). 
Dopamine agonists (e.g., amphetamine) have also been shown to produce rate-
dependent effects on responding (Dews, 1958; Lucki & DeLong, 1983). Rate dependency 
occurs when drugs decrease responding that occurs at a high rate and concomitantly 
increase responding that occurs at a low rate (see Branch, 1984). As it pertains to the 
present experiment, response rates from PPX sessions (expressed as a proportion of 
saline rates) were examined for rate-dependency using a three-way, repeated-measures 
ANOVA (Delay Condition, Dose, Lever). 
In the acute assessment, one rat (P1) fell ill, was euthanized, and was excluded 
from all analyses. In the chronic assessment, response allocation failed to stabilize for 
two rats (G3 and P2) in the third and final delay condition. Data from these two subjects 
were excluded from statistical analyses comparing acute and chronic assessments. 
Pairwise comparisons were evaluated using Bonferroni-corrected alphas. Effects 
sizes were calculated as generalized eta squared (see Bakeman, 2005). For cases where 
data violated assumptions of normality, Greenhouse-Geisser adjusted degrees of freedom 
were used to estimate criterion for significance. All effects and interactions were 
significant at the p < .05 level. 
Results 
 Rats required an average of 27.55 (SD = 9.35) and 29.22 (SD = 7.91) sessions to 
achieve stability prior to acute and chronic PPX assessments, respectively (Table 3-1).  
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Table 3-1 
Sequence of Delay Conditions and Sessions to Stability for Individual Rats in the Acute 
and Chronic PPX Assessments of Experiment 1 
  Acute  Chronic 
 
Rat 
Delay (s) 
(Left/Right) 
 
Condition 
Sessions to 
Stability 
  
Condition 
Sessions to 
Stability 
G1 7.5/7.5 1 23  3 25 
 12/3 2 24  2 23 
 3/12 3 30  1 - 
G2 7.5/7.5 1 22  3 56 
 12/3 2 23  2 22 
 3/12 3 30  1 - 
G3 7.5/7.5 1 22  - - 
 12/3 2 20  - - 
 3/12 3 26  - - 
G4 7.5/7.5 1 20  3 39 
 12/3 2 20  2 34 
 3/12 3 40  1 - 
R1B1 7.5/7.5 1 22  3 23 
 12/3 2 24  2 27 
 3/12 3 44  1 - 
R1B2 7.5/7.5 1 20  3 33 
 12/3 2 22  2 28 
 3/12 3 34  1 - 
R1B3 7.5/7.5 1 23  3 30 
 12/3 3 47  1 - 
 3/12 2 23  2 27 
P2 7.5/7.5 1 20  - - 
 12/3 3 45  - - 
 3/12 2 21  - - 
B1R1 7.5/7.5 1 20  3 23 
 12/3 3 47  1 - 
 3/12 2 20  2 25 
B1R2 7.5/7.5 1 20  3 33 
 12/3 3 42  1 - 
 3/12 2 24  2 27 
B1R3 7.5/7.5 1 23  3 23 
 12/3 3 46  1 - 
 3/12 2 22  2 28 
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For rats completing both assessments, significantly more sessions were required to 
achieve stability prior to the chronic assessment, F(1, 9) = 13.55, p < .01, G
2
 = .31. 
Figure 3-1 depicts the effects of acute PPX on sensitivity to relative reinforcer 
delay (d; top graph) and bias (log b; bottom graph) for individual subjects and for the 
group average (see Table 3-2 for individual-subject parameter estimates). Sensitivity to 
relative reinforcer delay was significantly reduced by acute PPX, F(1.64, 16.4) = 13.98, p 
< .001, G
2
 = .58, in a dose-dependent manner (significant linear contrast: F[1, 10] = 
18.616, p = .002, G
2
 = .65). Bonferroni-corrected pairwise comparisons revealed that the 
only PPX dose at which sensitivity to relative reinforcer delay was significantly lower 
than saline was 0.3 mg/kg (p = .02). Sensitivity at higher PPX doses (0.1, 0.18, and 0.3 
mg/kg) was also significantly lower than sensitivity at the 0.03 mg/kg dose (all p’s < .03). 
Bias was unaffected by acute PPX (p > .20). Table 3-3 also displays left- and right-lever 
response output (on which the above regressions were performed), left and right local 
response rates, and changeover responses emitted at each acute saline or PPX 
administration in each delay condition for each rat. 
Sensitivity to relative reinforcer delay and bias under chronic PPX (0.18 mg/kg) 
administration (Figure 3-2) did not differ significantly from chronic saline sessions (p = 
.07 and .11, respectively). However, when compared to sensitivity at the same dose when 
administered acutely, sensitivity under chronic PPX administration was significantly 
higher, t(8) = -4.11, p = .003. Bias, on the other hand, was not significantly affected by 
PPX assessment (p > .35). Table 3-4 displays mean left- and right-lever response output, 
mean left and right local response rates, and mean changeover responses emitted 
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Figure 3-1. Parameters of best-fitting linear regressions of individual-subject initial-link 
response allocation from the acute PPX assessment of Experiment 1. Each point 
corresponds to an individual subject’s sensitivity to relative reinforcer delays (d) or bias 
(log b) estimate with solid lines representing group averages. Asterisk denotes dose is 
significantly different from saline at the p < .05 level. 
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Table 3-2 
Parameter Estimates from the Acute and Chronic PPX Assessments of Experiment 1 
  Acute  Chronic 
 
Rat 
PPX 
(mg/kg) 
Slope 
(d) 
Bias 
(log b) 
VAC 
(R
2
) 
 Slope 
(d) 
Bias 
(log b) 
VAC 
(R
2
) 
G1 Saline 0.72 0.40 1.00  0.59 0.54 0.91 
 0.03 0.92 0.29 1.00     
 0.1 0.64 0.17 0.99     
 0.18 0.41 0.15 0.84  0.67 0.34 0.99 
 0.3 0.48 0.17 0.93     
         
G2 Saline 1.40 0.04 1.00  1.82 -0.03 1.00 
 0.03 1.63 0.13 0.96     
 0.1 0.86 -0.08 0.99     
 0.18 0.78 -0.03 1.00  0.98 0.08 0.99 
 0.3 0.80 -0.17 0.98     
         
G3 Saline 0.68 -0.45 0.89  - - - 
 0.03 0.88 -0.34 0.98     
 0.1 0.75 -0.12 0.95     
 0.18 0.65 -0.06 0.99  - - - 
 0.3 0.69 0.01 0.96     
         
G4 Saline 1.12 -0.02 1.00  1.32 -0.10 0.88 
 0.03 0.84 -0.03 0.99     
 0.1 0.56 -0.03 1.00     
 0.18 0.61 -0.05 0.95  0.77 -0.02 0.97 
 0.3 0.53 -0.13 0.81     
         
R1B1 Saline 1.58 0.00 1.00  0.93 0.26 0.95 
 0.03 1.50 -0.03 1.00     
 0.1 0.67 0.01 1.00     
 0.18 0.49 0.06 0.99  0.80 0.14 0.93 
 0.3 0.46 0.04 0.99     
         
R1B2 Saline 0.60 0.28 0.93  0.49 0.52 0.98 
 0.03 0.60 0.26 0.99     
 0.1 0.58 0.20 0.98     
 0.18 0.56 0.14 1.00  0.71 0.25 0.94 
 0.3 0.35 0.06 1.00     
 
 (table continues) 
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  Acute  Chronic 
 
Rat 
PPX 
(mg/kg) 
Slope 
(d) 
Bias 
(log b) 
VAC 
(R
2
) 
 Slope 
(d) 
Bias 
(log b) 
VAC 
(R
2
) 
R1B3 Saline 0.87 -0.03 0.98  0.83 -0.06 0.90 
 0.03 0.75 -0.03 0.94     
 0.1 0.44 -0.03 0.86     
 0.18 0.48 0.01 0.92  0.76 -0.03 1.00 
 0.3 0.53 -0.02 0.88     
         
P2 Saline 0.35 -0.05 0.73  - - - 
 0.03 0.38 0.09 0.99     
 0.1 0.30 -0.02 0.99     
 0.18 0.23 -0.03 0.78  - - - 
 0.3 0.32 -0.02 0.82     
         
B1R1 Saline 0.87 0.14 0.68  0.72 0.06 0.99 
 0.03 0.86 0.07 0.82     
 0.1 0.75 0.06 0.99     
 0.18 0.57 0.01 0.99  0.59 -0.03 1.00 
 0.3 0.26 0.17 0.37     
         
B1R2 Saline 0.48 0.10 0.90  0.73 0.13 1.00 
 0.03 0.69 0.05 0.97     
 0.1 0.43 0.10 0.98     
 0.18 0.59 0.12 1.00  0.52 0.03 0.98 
 0.3 0.34 0.09 0.77     
         
B1R3 Saline 1.14 0.10 0.95  1.21 0.09 0.99 
 0.03 1.11 0.16 0.97     
 0.1 0.73 0.06 0.99     
 0.18 0.48 0.05 0.98  0.68 -0.02 0.96 
 0.3 0.55 0.08 0.85     
Note. Slope (sensitivity to relative reinforcer delays; d), bias (log b), 
and variance accounted for (VAC; R
2
) estimates from best-fitting 
linear regressions of response allocation in the acute and chronic 
PPX assessments. 
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Table 3-3 
Behavioral Measures from the Acute PPX Assessment of Experiment 1 
   Left lever Right lever  
 
Rat 
Delay pair 
(Left/right) 
PPX 
(mg/kg) 
 
Responses 
Local 
rate 
 
Responses 
Local 
rate 
Changeover 
events 
G1 7.5 s/7.5 s Saline 850/981 1.32/2.09 309/426 1.29/2.11 46/54 
  0.03 893/789 1.51/1.41 391/428 1.63/1.27 56/56 
  0.1 516/682 0.84/1.35 324/407 1.04/1.35 57/60 
  0.18 516/480 0.91/1.24 415/487 1.30/1.11 51/52 
  0.3 327/468 0.37/0.78 327/309 0.67/0.79 46/71 
 12 s/3 s Saline 807/673 1.89/2.10 595/729 1.95/1.88 54/65 
  0.03 608/480 1.87/1.46 791/879 1.89/1.80 51/72 
  0.1 493/377 0.84/1.35 619/684 1.32/1.18 62/68 
  0.18 440/316 0.85/0.93 378/394 0.80/0.69 49/46 
  0.3 350/322 0.56/0.91 319/423 0.39/0.60 47/61 
 3 s/12 s Saline 1126/1239 2.38/2.15 277/154 1.25/1.00 59/33 
  0.03 1169/1176 1.65/1.83 209/207 1.17/1.22 36/36 
  0.1 602/675 0.40/1.06 186/250 0.58/0.62 59/66 
  0.18 339/544 0.14/0.69 184/150 0.49/0.45 48/50 
  0.3 414/762 0.57/0.56 214/188 0.72/0.54 38/50 
        
G2 7.5 s/7.5 s Saline 525/632 1.19/1.23 557/458 1.41/1.36 62/64 
  0.03 422/339 0.88/0.83 433/465 1.03/1.02 59/52 
  0.1 304/349 0.70/0.80 438/462 0.75/0.91 57/56 
  0.18 382/317 0.78/0.71 297/465 0.85/0.75 38/65 
  0.3 201/341 0.40/0.33 343/331 0.40/0.36 45/46 
 12 s/3 s Saline 258/212 1.01/1.06 1131/1180 1.30/1.41 63/71 
  0.03 239/195 0.83/0.95 793/926 1.17/1.12 68/58 
  0.1 230/188 0.70/0.80 568/729 0.93/0.92 57/55 
  0.18 199/200 0.44/0.68 520/562 0.68/0.72 52/65 
  0.3 170/116 0.35/0.53 575/562 0.42/0.22 44/33 
 3 s/12 s Saline 1191/1194 1.49/1.66 207/224 1.85/1.96 30/39 
  0.03 1293/1273 1.62/1.50 105/117 1.26/1.12 23/25 
  0.1 662/716 1.15/1.04 315/248 1.27/0.87 41/43 
  0.18 456/689 0.75/1.00 242/231 0.72/0.99 41/52 
  0.3 388/436 0.51/0.44 316/201 0.40/0.34 82/46 
        
G3 7.5 s/7.5 s Saline 228/193 0.36/0.56 420/443 0.63/0.51 27/32 
  0.03 210/215 0.49/0.55 401/365 0.42/0.53 33/35 
  0.1 326/310 0.50/0.60 330/330 0.44/0.56 47/37 
  0.18 219/221 0.44/0.45 314/251 0.45/0.41 59/47 
  0.3 222/230 0.35/0.49 203/364 0.30/0.44 50/36 
 
(table continues) 
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   Left lever Right lever  
 
Rat 
Delay pair 
(Left/right) 
PPX 
(mg/kg) 
 
Responses 
Local 
rate 
 
Responses 
Local 
rate 
Changeover 
events 
 12 s/3 s Saline 174/111 0.98/1.33 776/1303 0.74/1.17 44/28 
  0.03 152/178 1.04/1.03 1028/1200 0.85/0.86 41/38 
  0.1 144/167 0.50/0.60 507/597 0.51/0.58 31/37 
  0.18 196/163 0.51/0.47 299/583 0.38/0.48 37/46 
  0.3 187/177 0.46/0.55 310/434 0.39/0.47 43/37 
 3 s/12 s Saline 421/650 1.46/1.38 830/728 1.21/1.10 27/42 
  0.03 626/569 1.43/1.46 527/496 0.91/0.89 51/57 
  0.1 512/629 1.19/1.11 353/324 0.60/0.51 51/40 
  0.18 495/577 0.77/0.95 325/232 0.51/0.56 61/42 
  0.3 471/862 0.51/0.91 216/295 0.48/0.69 42/36 
        
G4 7.5 s/7.5 s Saline 642/544 1.42/1.60 549/791 1.36/1.51 64/45 
  0.03 504/410 1.26/1.17 509/601 1.08/1.13 53/57 
  0.1 462/393 1.05/1.09 407/509 0.92/1.03 60/48 
  0.18 434/416 1.01/0.81 342/455 0.88/0.78 50/44 
  0.3 267/355 0.82/0.79 313/281 0.63/0.77 42/40 
 12 s/3 s Saline 315/250 1.32/1.16 1006/1130 1.56/1.64 56/50 
  0.03 354/281 1.23/1.23 677/1085 1.22/1.66 54/49 
  0.1 275/413 1.05/1.09 585/861 1.01/1.16 53/65 
  0.18 303/265 1.02/0.87 689/746 1.14/1.07 53/61 
  0.3 200/228 0.60/0.60 386/1063 0.63/0.81 48/37 
 3 s/12 s Saline 994/1178 1.85/2.23 381/230 1.17/1.49 58/34 
  0.03 868/957 1.50/1.69 301/387 1.00/1.15 50/64 
  0.1 641/572 1.32/1.17 267/440 1.01/0.90 41/56 
  0.18 474/778 1.28/1.22 400/330 0.99/0.99 50/68 
  0.3 353/508 0.43/0.69 249/547 0.57/0.75 41/41 
        
R1B1 7.5 s/7.5 s Saline 761/587 2.89/2.74 651/815 2.10/2.23 60/57 
  0.03 659/650 2.64/2.07 743/762 1.91/2.15 51/58 
  0.1 582/717 0.94/1.70 570/672 0.67/1.32 72/50 
  0.18 662/485 1.03/1.06 533/523 0.63/0.96 178/162 
  0.3 714/390 0.58/0.65 512/392 0.34/0.49 223/200 
 12 s/3 s Saline 242/158 1.59/1.11 1167/1236 2.13/1.64 37/49 
  0.03 211/161 1.20/1.06 1130/1104 1.47/1.34 49/53 
  0.1 391/316 0.94/1.70 922/641 1.30/1.17 61/58 
  0.18 378/456 1.34/0.30 660/562 1.12/0.77 92/104 
  0.3 428/402 0.71/1.01 753/614 0.49/0.87 127/114 
 3 s/12 s Saline 1113/1191 1.54/1.63 171/178 0.90/0.81 63/61 
  0.03 927/880 1.35/1.62 154/170 0.68/0.64 46/43 
  0.1 645/515 1.21/0.75 201/339 0.50/0.41 70/87 
  0.18 709/296 0.48/0.24 207/219 0.34/0.26 182/142 
  0.3 437/430 0.54/0.38 213/265 0.42/0.29 133/206 
 
(table continues) 
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   Left lever Right lever  
 
Rat 
Delay pair 
(Left/right) 
PPX 
(mg/kg) 
 
Responses 
Local 
rate 
 
Responses 
Local 
rate 
Changeover 
events 
R1B2 7.5 s/7.5 s Saline 547/700 1.00/1.35 404/406 1.14/1.31 55/52 
  0.03 723/669 1.15/1.01 431/292 1.34/1.00 50/41 
  0.1 405/612 0.82/1.00 304/274 0.71/0.93 52/33 
  0.18 331/532 0.64/0.78 324/294 0.71/0.89 47/39 
  0.3 328/363 0.6/0.39 387/231 0.48/0.42 42/42 
 12 s/3 s Saline 594/488 1.31/1.41 453/587 1.08/1.08 58/43 
  0.03 488/383 1.25/1.04 478/514 0.92/0.91 42/43 
  0.1 401/314 0.82/1.00 444/492 0.80/0.90 44/37 
  0.18 363/285 0.83/0.76 449/445 0.72/0.73 44/44 
  0.3 283/239 0.54/0.76 287/418 0.55/0.64 33/39 
 3 s/12 s Saline 974/1074 1.55/1.58 274/208 1.06/1.13 53/38 
  0.03 816/796 1.24/0.97 243/210 1.02/1.04 42/39 
  0.1 684/603 0.91/0.80 208/223 0.92/0.98 35/38 
  0.18 613/455 0.80/0.60 171/231 0.77/0.49 33/62 
  0.3 288/419 0.48/0.43 233/168 0.46/0.49 36/57 
        
R1B3 7.5 s/7.5 s Saline 706/536 2.27/2.45 698/873 2.26/2.53 57/59 
  0.03 520/663 1.81/1.99 882/739 1.94/2.14 65/55 
  0.1 550/444 1.65/1.76 695/653 1.57/1.25 64/57 
  0.18 444/520 1.30/1.45 507/622 1.21/1.17 55/66 
  0.3 376/377 0.96/1.36 501/504 0.82/0.92 49/41 
 3 s/12 s Saline 989/1101 2.47/2.54 430/326 2.75/2.71 39/38 
  0.03 874/1098 1.61/1.79 523/290 2.20/2.14 53/30 
  0.1 719/761 1.48/1.19 483/351 1.58/1.57 52/38 
  0.18 586/641 1.19/0.79 319/294 1.15/1.15 46/40 
  0.3 512/698 0.98/0.57 278/304 0.81/0.27 45/41 
 12 s/3 s Saline 403/350 4.00/3.57 1016/1068 3.77/3.50 27/27 
  0.03 468/387 2.45/2.26 945/1008 2.40/2.06 36/42 
  0.1 519/481 1.65/1.76 707/907 1.17/1.84 55/48 
  0.18 388/490 0.51/0.93 687/674 0.56/0.87 60/70 
  0.3 251/347 0.79/0.62 511/482 0.79/0.55 42/64 
        
P2 7.5 s/7.5 s Saline 380/427 1.05/1.00 611/609 1.18/1.32 61/65 
  0.03 461/545 0.76/0.91 360/414 0.94/0.99 65/50 
  0.1 269/269 0.75/0.54 305/242 0.70/0.66 47/37 
  0.18 264/256 0.58/0.53 307/354 0.68/0.68 54/71 
  0.3 229/196 0.20/0.16 244/309 0.23/0.19 60/64 
 3 s/12 s Saline 721/818 1.42/1.27 566/428 1.55/1.70 55/49 
  0.03 537/469 0.70/0.77 202/344 1.13/1.24 32/47 
  0.1 395/345 0.60/0.36 302/251 0.65/0.89 59/47 
  0.18 264/436 0.42/0.49 230/288 0.23/0.50 61/101 
  0.3 239/391 0.09/0.26 196/200 0.24/0.33 36/48 
 
(table continues) 
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   Left lever Right lever  
 
Rat 
Delay pair 
(Left/right) 
PPX 
(mg/kg) 
 
Responses 
Local 
rate 
 
Responses 
Local 
rate 
Changeover 
events 
 12 s/3 s Saline 599/503 1.56/1.97 776/834 2.27/2.22 59/47 
  0.03 423/283 1.21/0.76 573/354 1.31/0.82 48/54 
  0.1 286/249 0.75/0.54 398/408 0.57/0.61 58/104 
  0.18 240/219 0.30/0.52 271/318 0.44/0.55 53/80 
  0.3 210/221 0.18/0.42 285/312 0.20/0.34 57/43 
        
B1R1 7.5 s/7.5 s Saline 535/465 1.43/1.81 735/876 1.73/1.85 73/61 
  0.03 447/505 1.49/1.54 619/790 1.36/1.51 56/60 
  0.1 404/416 1.02/1.02 396/405 0.87/0.87 64/63 
  0.18 350/441 0.59/1.09 337/535 0.64/1.02 82/67 
  0.3 293/210 0.29/0.24 208/341 0.39/0.58 81/62 
 3 s/12 s Saline 1167/1238 1.76/2.08 240/180 1.28/1.89 73/39 
  0.03 1145/1030 1.46/1.24 249/259 1.77/1.38 31/53 
  0.1 704/752 0.89/0.96 286/219 0.92/1.01 64/55 
  0.18 415/552 0.56/0.62 191/270 0.53/0.82 54/84 
  0.3 556/467 0.54/0.35 157/251 0.47/0.58 59/93 
 12 s/3 s Saline 631/550 2.15/2.03 762/840 2.12/2.17 58/65 
  0.03 406/418 0.96/1.28 700/776 1.36/1.54 66/70 
  0.1 341/271 1.02/1.02 549/677 1.04/0.96 63/57 
  0.18 314/235 0.63/0.79 442/555 0.49/0.95 100/49 
  0.3 502/207 0.52/0.76 228/243 0.21/0.31 133/51 
        
B1R2 7.5 s/7.5 s Saline 520/573 1.13/1.27 282/416 0.84/1.20 88/115 
  0.03 369/415 0.91/0.92 283/306 0.82/0.87 67/75 
  0.1 230/335 0.24/0.65 150/264 0.04/0.57 54/64 
  0.18 280/290 0.44/0.71 191/235 0.09/0.33 82/61 
  0.3 339/222 0.57/0.26 183/162 0.12/0.40 61/57 
 3 s/12 s Saline 686/824 1.23/1.49 354/405 1.42/1.87 83/71 
  0.03 712/692 1.15/1.35 238/373 1.08/1.54 56/70 
  0.1 450/504 0.79/0.53 174/325 0.82/0.95 44/66 
  0.18 403/418 0.54/0.85 139/186 0.58/0.82 42/44 
  0.3 385/431 0.32/0.28 310/203 0.36/0.70 61/54 
 12 s/3 s Saline 543/532 1.74/1.89 835/848 2.05/2.02 81/80 
  0.03 504/348 1.78/1.31 876/924 1.73/1.84 69/59 
  0.1 409/481 0.24/0.65 598/627 1.28/1.51 71/61 
  0.18 386/472 0.97/1.36 651/682 0.65/1.47 78/58 
  0.3 272/369 0.72/0.58 365/535 0.76/0.49 44/54 
        
B1R3 7.5 s/7.5 s Saline 834/969 2.04/2.42 558/448 2.04/2.53 65/49 
  0.03 847/990 1.90/2.23 556/419 2.04/2.25 51/37 
  0.1 674/720 1.61/1.44 652/647 1.92/1.72 45/45 
  0.18 390/790 0.91/1.56 533/552 1.16/1.70 69/51 
  0.3 286/525 0.64/0.90 403/478 0.85/1.31 65/65 
 
(table continues) 
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   Left lever Right lever  
 
Rat 
Delay pair 
(Left/right) 
PPX 
(mg/kg) 
 
Responses 
Local 
rate 
 
Responses 
Local 
rate 
Changeover 
events 
 3 s/12 s Saline 1054/1205 2.21/2.63 363/214 2.38/2.51 42/28 
  0.03 1153/1172 2.29/2.33 264/243 2.18/1.85 38/31 
  0.1 984/1056 1.49/1.56 403/332 1.60/1.62 44/33 
  0.18 608/819 0.67/1.11 292/402 0.44/1.28 73/41 
  0.3 807/552 0.86/0.59 331/187 1.07/1.19 61/27 
 12 s/3 s Saline 352/267 1.91/2.11 1046/1128 2.74/2.60 53/37 
  0.03 306/395 1.34/1.61 1082/983 1.85/2.05 58/58 
  0.1 437/430 1.61/1.44 927/755 1.74/1.64 53/70 
  0.18 495/404 1.24/0.86 677/668 1.37/1.15 65/86 
  0.3 309/315 0.79/0.75 456/385 1.02/0.91 82/50 
Note. Left and right lever response output, left and right local response rates, and 
changeover events in the first/second administration of each acute PPX dose for 
individual rats in each delay condition. 
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Figure 3-2. Parameters of best-fitting linear regressions of individual-subject initial-link 
response allocation from the chronic PPX assessment of Experiment 1. Each point 
corresponds to an individual subject’s sensitivity to relative reinforcer delays (d) or bias 
(log b) estimate with solid lines representing group averages. 
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Table 3-4 
Behavioral Measures from the Chronic PPX Assessment of Experiment 1 
   Left lever Right lever  
 
Rat 
Delay pair 
(Left/right) 
PPX 
(mg/kg) 
 
Responses 
Local 
rate 
 
Responses 
Local 
rate 
Changeover 
events 
G1 3 s/12 s Saline 1245.75 
(18.94) 
2.59 
(0.05) 
165.25 
(20.04) 
1.74 
(0.07) 
27.75   
(3.11) 
  0.18 1019.00 
(70.59) 
1.17 
(0.07) 
221.50 
(9.06) 
1.23 
(0.08) 
55.25   
(4.17) 
 12 s/3 s Saline 920.50 
(18.97) 
2.57 
(0.04) 
470.75 
(18.88) 
1.44 
(0.05) 
64.50     
(1.89) 
  0.18 479.50 
(48.64) 
1.17 
(0.11) 
497.00 
(30.19) 
1.13 
(0.06) 
64.75   
(4.42) 
 7.5 s/7.5 s Saline 1013.75 
(10.67) 
2.79 
(0.08) 
379.50 
(10.94) 
1.30 
(0.05) 
81.00        
(0.87) 
  0.18 620.75 
(40.15) 
1.05 
(0.12) 
267.00 
(14.47) 
0.79 
(0.07) 
60.25   
(3.09) 
        
G2 3 s/12 s Saline 1229.50 
(19.69) 
1.54 
(0.08) 
176.50 
(22.14) 
1.55 
(0.05) 
32.50     
(3.01) 
  0.18 928.25 
(57.94) 
1.13 
(0.04) 
231.75 
(25.86) 
1.08 
(0.13) 
53.00        
(6.53) 
 12 s/3 s Saline 128.25 
(10.33) 
1.53 
(0.08) 
1278.00 
(13.99) 
1.61 
(0.13) 
32.00          
(1.90) 
  0.18 275.00  
(16.63) 
1.08 
(0.02) 
673.25 
(29.20) 
0.91 
(0.11) 
66.25   
(4.55) 
 7.5 s/7.5 s Saline 585.25 
(24.67) 
1.45 
(0.04) 
537.50 
(12.70) 
1.49 
(0.04) 
68.75   
(0.96) 
  0.18 325.50 
(24.07) 
0.62 
(0.10) 
301.50 
(12.77) 
0.54 
(0.07) 
98.25 
(19.44) 
        
G4 3 s/12 s Saline 1167.25 
(8.97) 
2.14 
(0.03) 
224.75 
(9.58) 
1.10 
(0.13) 
39.75   
(0.89) 
  0.18 887.75 
(6.84) 
1.65 
(0.04) 
343.25 
(25.74) 
1.20 
(0.05) 
64.50     
(2.36) 
 12 s/3 s Saline 272.00  
(29.29) 
2.20 
(0.05) 
1125.75 
(28.31) 
2.03 
(0.05) 
28.50     
(1.92) 
  0.18 323.75 
(35.14) 
1.24 
(0.12) 
741.00 
(49.79) 
1.29 
(0.09) 
60.00        
(3.52) 
 7.5 s/7.5 s Saline 389.00  
(33.12) 
1.32 
(0.09) 
912.50 
(30.47) 
1.75 
(0.08) 
50.00        
(2.03) 
  0.18 346.00  
(30.75) 
0.78 
(0.10) 
432.75 
(38.93) 
1.01 
(0.10) 
108.00    
(14.95) 
 
(table continues) 
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   Left lever Right lever  
 
Rat 
Delay pair 
(Left/right) 
PPX 
(mg/kg) 
 
Responses 
Local 
rate 
 
Responses 
Local 
rate 
Changeover 
events 
R1B1 3 s/12 s Saline 1169.50 
(14.95) 
1.67 
(0.02) 
184.25 
(8.17) 
0.98 
(0.02) 
55.75   
(2.61) 
  0.18 863.00  
(57.61) 
1.18 
(0.12) 
212.50 
(16.78) 
0.79 
(0.05) 
79.75   
(8.58) 
 12 s/3 s Saline 302.50    
(12.00) 
1.12 
(0.08) 
428.50 
(15.61) 
0.78 
(0.02) 
75.25   
(7.13) 
  0.18 363.25 
(17.73) 
0.92 
(0.03) 
593.00 
(57.29) 
0.93 
(0.14) 
102.50   
(4.93) 
 7.5 s/7.5 s Saline 358.75 
(14.47) 
1.42 
(0.05) 
261.50 
(9.04) 
0.54 
(0.01) 
58.00        
(3.18) 
  0.18 348.00  
(29.88) 
0.62 
(0.03) 
340.25 
(29.85) 
0.39 
(0.05) 
150.25 
(22.41) 
        
R1B2 3 s/12 s Saline 1180.75 
(13.24) 
1.81 
(0.01) 
190.75 
(6.70) 
1.05 
(0.03) 
42.50       
(1.60) 
  0.18 725.50 
(41.56) 
0.80 
(0.02) 
158.00 
(13.02) 
0.92 
(0.03) 
28.50     
(1.68) 
 12 s/3 s Saline 795.00  
(19.46) 
1.72 
(0.02) 
412.00 
(11.97) 
1.26 
(0.01) 
60.00        
(2.26) 
  0.18 362.75 
(14.90) 
0.94 
(0.02) 
417.50 
(8.26) 
0.69 
(0.01) 
40.50     
(1.25) 
 7.5 s/7.5 s Saline 946.50 
(17.34) 
1.92 
(0.04) 
312.00   
(5.09) 
1.06 
(0.03) 
58.00          
(1.70) 
  0.18 414.75 
(20.49) 
0.89 
(0.03) 
298.75 
(13.52) 
0.81 
(0.03) 
36.25    
(4.64) 
        
R1B3 12 s/3 s Saline 305.25 
(20.67) 
3.19 
(0.07) 
1121.00 
(18.30) 
3.54 
(0.10) 
30.00        
(1.62) 
  0.18 386.50 
(31.82) 
1.90 
(0.14) 
997.50 
(28.84) 
1.58 
(0.11) 
45.00          
(2.50) 
 3 s/12 s Saline 925.50 
(18.41) 
3.14 
(0.07) 
485.50 
(17.76) 
2.77 
(0.03) 
37.50     
(1.03) 
  0.18 768.50 
(18.55) 
1.21 
(0.09) 
340.25 
(32.95) 
1.16 
(0.10) 
54.25   
(4.13) 
 7.5 s/7.5 s Saline 783.75 
(6.91) 
2.99 
(0.06) 
628.00   
(7.75) 
2.77 
(0.03) 
44.75   
(0.82) 
  0.18 323.75 
(15.07) 
0.82 
(0.03) 
352.75 
(13.34) 
0.84 
(0.06) 
50.50     
(2.25) 
        
B1R1 12 s/3 s Saline 442.50 
(14.10) 
1.95 
(0.02) 
948.50 
(13.95) 
2.34 
(0.05) 
64.75   
(2.41) 
  0.18 286.00  
(10.11) 
0.99 
(0.06) 
611.25 
(34.38) 
1.01 
(0.06) 
56.00        
(2.67) 
 
(table continues) 
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   Left lever Right lever  
 
Rat 
Delay pair 
(Left/right) 
PPX 
(mg/kg) 
 
Responses 
Local 
rate 
 
Responses 
Local 
rate 
Changeover 
events 
 3 s/12 s Saline 1004.00  
(7.87) 
2.20 
(0.07) 
395.50    
(8.00) 
2.40 
(0.12) 
54.75   
(4.08) 
  0.18 543.50 
(42.62) 
0.80 
(0.05) 
293.00 
(27.29) 
0.92 
(0.08) 
47.25   
(1.98) 
 7.5 s/7.5 s Saline 771.25 
(13.42) 
2.01 
(0.10) 
617.25 
(10.65) 
2.09 
(0.08) 
71.75   
(5.02) 
  0.18 408.50 
(18.32) 
0.83 
(0.02) 
446.00 
(16.42) 
1.14 
(0.04) 
60.25   
(2.46) 
        
B1R2 12 s/3 s Saline 502.00    
(7.42) 
2.13 
(0.01) 
886.25 
(7.58) 
2.17 
(0.04) 
77.00        
(2.85) 
  0.18 368.00    
(7.88) 
1.31 
(0.01) 
663.25 
(22.84) 
1.30   
(0.10) 
70.25   
(1.95) 
 3 s/12 s Saline 1047.50 
(12.42) 
2.16 
(0.08) 
340.25 
(10.68) 
1.50   
(0.10) 
62.25   
(5.25) 
  0.18 492.00  
(42.33) 
1.06 
(0.05) 
265.00   
(21.60) 
1.03 
(0.05) 
63.75   
(5.13) 
 7.5 s/7.5 s Saline 825.25 
(7.35) 
2.57 
(0.08) 
568.00   
(7.06) 
1.84 
(0.05) 
82.00        
(2.52) 
  0.18 327.25 
(26.82) 
0.90 
(0.17) 
282.00 
(25.79) 
0.89 
(0.05) 
64.00        
(3.52) 
        
B1R3 12 s/3 s Saline 305.25 
(10.16) 
1.90 
(0.08) 
1093.75 
(8.78) 
2.58 
(0.07) 
53.25   
(2.48) 
  0.18 364.75 
(26.75) 
1.40 
(0.03) 
904.75 
(29.68) 
1.76 
(0.03) 
66.00        
(3.08) 
 3 s/12 s Saline 1158.25 
(15.86) 
2.64 
(0.03) 
251.25 
(16.13) 
2.04 
(0.06) 
48.50     
(4.25) 
  0.18 825.00  
(17.51) 
1.47 
(0.05) 
427.00   
(6.31) 
1.51 
(0.02) 
73.50     
(3.88) 
 7.5 s/7.5 s Saline 835.25 
(17.20) 
2.49 
(0.08) 
562.00 
(17.12) 
2.37 
(0.04) 
78.75   
(2.13) 
  0.18 485.00  
(14.39) 
1.05 
(0.09) 
421.75 
(15.32) 
1.30 
(0.07) 
86.00      
(11.59) 
Note. Mean left and right lever response output, mean left and right local response rates, 
and mean changeover responses emitted in the final four sessions at each chronic PPX 
dose for individual rats in each delay condition. Standard error of the mean of the final 
four administrations per dose is in parentheses. 
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over the final four sessions at each chronic saline or PPX administration in each delay 
condition for each rat. 
Figure 3-3 shows the effects of acute PPX on response perseveration. Overall, 
increasing the PPX dose decreased bout length; however, this effect depended on the 
terminal-link delay condition, significant dose x delay condition interaction, F(2.45, 
24.47) = 3.33, p < .05, G
2
 = .07. The simple main effect of dose was not investigated 
 
Figure 3-3. Bout length from each delay condition in the acute and chronic PPX 
assessments of Experiment 1. Acute and chronic data are shown in top and bottom 
panels, respectively. Each point represents an individual subject with solid lines 
representing group averages. 
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further because in only 11 out of 132 cases (9.84%) did PPX increase bout length above 
saline levels, many fewer instances than would have been expected had response 
perseveration influenced response allocation. 
 Relative to chronic saline, chronic PPX significantly reduced bout length, main 
effect of dose, F(1, 8) = 22.09, p = .002, G
2
 = .34. Bout length did not differ 
significantly between acute and chronic PPX assessments (p = .31), although a significant 
interaction with delay condition was detected, F(2, 16) = 5.33, p < .02, G
2
 = .11. Most 
importantly for the hypothesis that PPX increases the likelihood of response 
perseveration, in neither assessment did PPX significantly increase bout length. Thus, 
there was no evidence for a perseverative effect of PPX and the data were not analyzed 
further. 
Figure 3-4 depicts left- and right-lever response rates, expressed as a proportion 
 
Figure 3-4. Left- and right-lever response rate (expressed as proportion of saline rate) 
from each delay condition in the acute PPX assessment of Experiment 1. Each point 
represents an individual subject, with dashed and solid lines representing group averages 
for left and right levers, respectively. 
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of saline rates, as a function of acute PPX dose. Regardless of the delay associated with 
either the left or right levers, acute PPX significantly reduced response rates, F(3, 30) = 
205.47, p < .001, G
2
 = .59; this effect was dose-dependent, significant linear contrast, 
F(1, 10) = 678.37, p < .001, G
2
 = .71.  
Discussion 
Experiment 1 was designed to dissociate competing hypotheses regarding PPX-
induced changes in sensitivity to relative reinforcer delay in studies previously assessing 
the drug effect in intertemporal choice procedures. Increased SS choice with acute PPX 
administration was observed by Madden et al. (2010) and, if sensitivity to relative 
reinforcer delay was affected, could have resulted from an increase in sensitivity to LL 
delays. Koffarnus et al. (2011) also observed an increase in SS choice at the highest PPX 
dose investigated (0.32 mg/kg), but the form of the drug effect in their study suggested a 
nonspecific impairment of stimulus control. In the present experiment, acute PPX 
administration dose-dependently decreased rats’ sensitivity to relative terminal-link 
reinforcer delay in a concurrent-chains procedure. Chronic PPX (0.18 mg/kg) did not 
significantly affect sensitivity to relative reinforcer delay. Bias was also not significantly 
affected by the drug in either assessment. Alternative explanations for the drug’s effects 
on previous intertemporal choice studies, namely response perseveration and rate 
dependent increases in selection of the SS reinforcer, were not supported. 
That PPX decreased sensitivity to relative reinforcer delay is incompatible with 
the results of Madden et al. (2010). Decreased sensitivity to relative reinforcer delay is 
predicted to lead to more LL choices but Madden et al. (2010) reported the opposite. The 
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present findings are consistent with those of Koffarnus et al. (2011) and of the 
experiment presented in Chapter 2. In these studies, PPX flattened preference functions 
towards indifference in a manner resembling disruption of stimulus control of choice 
behavior. Impaired stimulus control could also manifest as a reduction in bias (log b), 
although biases were not apparent under nondrug conditions and therefore could not be 
reduced. 
As noted in Chapter 2, poor discrimination of reinforcer delays in intertemporal 
choice situations should increase LL choice if sensitivity to differences in reinforcer 
amount remains intact. However, no previous study has reported that PPX increases LL 
choice. Thus, impaired delay discrimination does not alone provide a satisfactory 
explanation for the behavioral patterns exhibited across these studies. Perhaps PPX 
impairs discrimination of the response-reinforcer contingency (i.e., observing/ 
remembering which response fulfilled the reinforcer contingency). Disruption of this 
elementary discrimination may equalize response allocation in both intertemporal choice 
and concurrent-chains procedures and was therefore the focus of Experiment 2. 
Experiment 2 
Introduction 
According to Davison and Nevin (1999), choice between two concurrently 
available alternatives is affected by the discriminability of the stimulus features that 
differentiate the alternatives. As a given stimulus feature (e.g., the color of cue lights that 
signal the two options), becomes increasingly similar along a shared dimension, 
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discriminability is reduced to chance levels. Essentially, as the confusability of two 
stimuli increases, choice should approach indifference, or 50% choice. The shared profile 
of the findings of Chapter 2 and of Experiment 1–namely, reduced sensitivity to relevant 
stimulus features (reinforcer amount and delay in Chapter 2 and terminal-link delays in 
Experiment 1)–suggests a critical discrimination was disrupted by PPX administration. 
One discrimination which, if disrupted, is capable of producing the PPX-induced 
disruptions seen in previous experiments is discrimination of the source of reinforcement 
or, more specifically, the response-reinforcer contingency (Davison & Jenkins, 1985). 
Once reinforcement is earned, the organism must discriminate the relation between its 
own behavior and production of the reinforcer. If PPX disrupts this discrimination, then 
reinforcement earned via the just-productive alternative could be misattributed to an 
unproductive alternative. The degree to which reinforcers are misattributed may also be 
influenced by stimulus features whose discrimination remains intact (e.g., reinforcer 
amount) or variables which may degrade the response-reinforcer contingency (e.g., delay 
to reinforcement). Evidence for the latter hypothesis is provided by research in the areas 
of memory and forgetting which has established the deleterious effects of intervening 
delays on discrimination performance (Blough, 1959; Chrobak & Napier, 1992; Etkin & 
D’Amato, 1969; Jans & Catania, 1980; Roberts, 1972b; Savage & Parsons, 1997; 
Wallace, Steinert, Scobie, & Spear, 1980; White, 1985).  
In the context of an intertemporal choice, if discrimination of response-reinforcer 
contingencies is compromised following choice of the LL reinforcer and further degraded 
by the intervening delay to reinforcement, the frequency of future SS choices may 
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increase because LL reinforcers are misattributed as the result of a response on the SS 
alternative. By this logic, because SS reinforcers are delivered immediately, one might 
predict greater fidelity in attribution to the SS alternative. This hypothesis may explain 
the pattern of results seen by Madden et al. (2010), in which PPX administration 
increased SS preference against a baseline preference for the LL reinforcer, but did not 
affect preference when the SS was highly preferred under baseline conditions, perhaps 
due to a ceiling effect. This hypothesis could also account for the indifference observed 
by Koffarnus et al. (2011): At longer delays to the LL reinforcer, differential 
misattribution of LL reinforcers to the SS response would shift preference away from LL 
choices and toward indifference.  
This hypothesis does not, however, provide a coherent account of the results of 
Chapter 2. In that experiment, under saline conditions rats preferred SS reinforcers at 
longer LL delays. The differential-misattribution hypothesis predicts that following PPX 
administration, LL reinforcers should have been misattributed to the SS alternative, 
thereby further increasing SS preference. This was not observed. Instead, in this range of 
delays choice shifted toward indifference; a pattern of results consistent with 
nondifferential misattribution of reinforcers to responses (i.e., a disruption of stimulus 
control). 
In order to examine the effects of PPX on discrimination of response-reinforcer 
contingencies, Experiment 2 incorporated a procedure used by researchers interested in 
signal detection (McCarthy & Davison, 1986), as well as memory and forgetting (Jones 
& Davison, 1998): the symbolic matching-to-sample (SMTS) procedure (see below for 
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full description and quantitative modeling). Additionally, Experiment 2 restricted 
investigation to chronic PPX, as previous research has suggested that chronic 
administration reduces the likelihood of interference from nonspecific drug effects (Maj 
et al., 2000), which were likely present in the acute assessments conducted in Chapter 2 
and Experiment 1 of the present paper. 
Methods 
Subjects. Twelve experimentally naïve male Wistar rats served as subjects and 
were treated identically to subjects serving in Experiment 1. Animal use was in 
accordance with the Institutional Animal Care and Use Committee (IACUC) of Utah 
State University. 
Apparatus. Sessions were conducted in standard operant conditioning chambers 
housed within sound-attenuating cubicles (Med Associates Inc., St. Albans, VT). Located 
on either side of the front wall were two retractable side levers with stimulus lamps 
located above each lever. Centered between the levers was a food receptacle into which a 
pellet dispenser (Med Associates Inc.) delivered 45 mg nutritional rodent pellets (Bio-
Serv, Frenchtown, NJ). On the opposite wall were two nose-poke operanda (left and right 
sides). The nose pokes were separated by a food receptacle serviced by an additional 45-
mg pellet dispenser (Coulbourn Instruments, Whitehall, PA). Chambers were equipped 
with a white noise speaker and ventilation fan. All experimental events were coordinated 
and recorded via a PC. 
Behavioral procedure. Experimental sessions consisted of 40 trials. For the first 
part of each trial (sample period), one of the levers was selected randomly without 
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replacement and inserted into the chamber accompanied by illumination of its stimulus 
lamp (20 trials per lever). A single response on this lever retracted the lever, extinguished 
its stimulus lamp and resulted in the delivery of 1 food pellet to the front receptacle. If a 
sample response did not occur within 15 s of lever insertion, the trial was terminated and 
counted as an omission. 
Immediately following reinforcer deliveries to the front receptacle, discrimination 
of the response that produced reinforcement was assessed (comparison period). First, the 
stimulus lights located within the rear nose pokes were illuminated. Next, a conditional 
discrimination was required such that the rat needed to make a single nose poke to the 
nose poke operandum symbolically associated with the sample response (e.g., if the pellet 
was earned on left lever, choose left nose poke). Failure to emit a comparison response 
within 15 s of illumination of the nose poke lights resulted in trial termination and the 
trial being counted as an omission. 
Correct responses extinguished all stimuli and resulted in the delivery of 1 food 
pellet to the rear receptacle. Incorrect responses produced the same series of events with a 
0.5-s blackout taking the place of pellet delivery. Following each trial, a 30-s ITI 
occurred during which all stimuli were in the off-state. 
For the first 20 sessions of the experiment, a correction procedure was 
implemented. During this period, trials in which samples were not identified correctly 
were repeated indefinitely until the correct discrimination was made. Sessions ended once 
40 correct discriminations were made or two hours had elapsed. The correction procedure 
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was then removed for 10 sessions, after which the chronic PPX assessment began 
regardless of baseline accuracy. 
Drug procedure. PPX (0.18 mg/kg) or saline vehicle was administered 
subcutaneously 10 minutes prior to every session for 14 consecutive sessions. After a 6-
day no-injection washout period, a second repeated dosing regimen was initiated with the 
compound not administered in the first regimen (order counterbalanced across subjects). 
Data analysis. Accuracy of rats’ discriminations of sample responses was 
calculated primarily as the percentage of correct discriminations. For reasons discussed 
below, accuracy was also calculated according to a signal-detection model forwarded by 
McCarthy, Davison, and Jenkins (1982): 
                 
   
   
 
   
   
 ,    (10) 
where RLL is the number of left nose pokes having just obtained a reinforcer from the left 
lever (correct discrimination) and RLR is the number of right nose pokes having just 
obtained a reinforcer from the left lever (incorrect discrimination); the same criteria apply 
to reinforcers earned from the right lever. By comparing accuracy following both left and 
right samples, log d, a measure of the accuracy of response discrimination, was obtained. 
The calculation of log d included events from the final four sessions of each chronic 
dosing regimen (saline and PPX). Perfect discrimination between the contingencies (i.e., 
the correct nose poke was always chosen) was indicated by a ceiling log d value of 2.51; 
chance responding resulted in a log d of 0. A correction to Equation 10 suggested by 
Brown and White (2005) in which 0.25 is added to each response count was adopted. 
Compared to a percent correct measure, log d expresses accuracy proportionately and is, 
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therefore, less likely to be influenced by the total number of trials considered in the 
calculation. Bias (i.e., favoring a particular comparison response over another due to non-
experimenter programmed variables) was calculated as log b: 
                 
   
   
 
   
   
 ,    (11) 
Because data failed to satisfy assumptions of normality, related-samples Wilcoxon 
signed-rank tests (nonparametric equivalent of paired-samples t test) were used to test for 
PPX-induced differences in the accuracy with which rats discriminated response-
reinforcer contingencies (log d), bias (log b), and omissions recorded during sessions. 
Effect sizes were calculated according to the method described by Field (2009). 
Results 
 Behavioral measures are displayed in Table 3-5. Figure 3-5 (top left) shows that 
the accuracy with which rats correctly discriminated the sample response during the 
chronic saline regimen approached the maximum log d value (M = 2.20, SD = 0.33); 6 
out of 12 rats discriminated the sample response with maximum accuracy. Chronic PPX 
(0.18 mg/kg) administration significantly reduced rats’ accuracy on the discrimination 
task (M = 0.89, SD = 0.33), z = -3.06, p < .01, ES = .62. When calculated as the 
percentage of trials with correct discriminations (Figure 3-5, top right), mean accuracy 
corresponded to 99.27% (SD = 0.84) and 85.66% (SD = 7.21) for the saline and PPX 
regimens, respectively. Thus, chronic PPX administration reduced the accuracy with 
which rats discriminated the response-reinforcer contingencies by an average of 13.62% 
(SD = 7.27). PPX did not reduce accuracy on left- (M = 12.67, SD = 8.71) or right-lever 
(M = 14.51, SD = 8.43) trials differentially (not shown; p > .5). 
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Table 3-5 
Parameter Estimates from Experiment 2 
 
Rat 
PPX 
(mg/kg) 
 
Log d 
 
Log b 
Percent 
correct (%) 
Percent left 
correct (%) 
Percent right 
correct (%) 
Omissions 
per session 
B1 Saline 2.51 0.00 100.00 100.00 100.00 0.00 (0.00) 
 0.18 0.84 0.00 88.41 87.69 87.50 5.75 (3.25) 
        
B2 Saline 2.15 0.35 99.38 100.00 98.75 0.00 (0.00) 
 0.18 0.86 0.03 88.13 88.75 87.50 0.00 (0.00) 
        
B3 Saline 1.80 0.00 98.75 98.75 98.75 0.00 (0.00) 
 0.18 0.89 -0.21 88.44 82.81 92.98 9.75 (5.45) 
        
B4 Saline 2.51 0.00 100.00 100.00 100.00 0.00 (0.00) 
 0.18 1.07 0.19 91.84 95.00 88.61 0.25 (0.25) 
        
B5 Saline 1.80 0.00 98.75 98.75 98.75 0.00 (0.00) 
 0.18 1.06 0.48 88.59 97.50 79.49 0.50 (0.29) 
        
B6 Saline 2.02 -0.48 98.75 97.50 100.00 0.00 (0.00) 
 0.18 1.07 0.42 89.22 97.22 81.82 2.75 (1.11) 
        
G1 Saline 2.51 0.00 100.00 100.00 100.00 0.00 (0.00) 
 0.18 1.65 -0.84 93.20 87.01 100.00 1.50 (1.50) 
        
G2 Saline 2.51 0.00 100.00 100.00 100.00 0.00 (0.00) 
 0.18 0.34 -0.01 59.65 68.42 69.57 19.00 (5.80) 
        
G3 Saline 2.51 0.00 100.00 100.00 100.00 0.00 (0.00) 
 0.18 0.43 0.02 72.84 73.91 72.22 19.50 (4.66) 
        
G4 Saline 1.88 -0.63 97.50 95.00 100.00 0.00 (0.00) 
 0.18 0.65 0.00 82.16 82.35 82.14 24.50 (3.77) 
        
G5 Saline 1.67 0.13 98.13 98.75 97.50 0.00 (0.00) 
 0.18 0.73 0.01 83.80 84.85 84.42 4.25 (1.70) 
        
G6 Saline 2.51 0.00 100.00 100.00 100.00 0.00 (0.00) 
 0.18 1.07 -0.07 92.24 91.14 93.42 1.25 (0.63) 
Note. Overall accuracy (calculated as log d and percentage correct), bias (log b), accuracy 
on left and right sample trials, and mean number of omissions per session at each chronic 
PPX dose for individual rats. Standard error of the mean of the final four administrations 
per dose is in parentheses. 
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Figure 3-5. Effects of chronic saline and PPX administration on behavioral measures in 
Experiment 2. Top left: Accuracy of rats’ discrimination of the response-reinforcer 
contingencies as log d (see text). Top right: The same accuracy data calculated as 
percentage of correct discriminations. Bottom left: Bias for a given comparison response 
independent of experimenter-programmed variable calculated as log b (see text). Bottom 
right: Mean number of omissions per session. Double asterisks identify behavioral 
measures significantly affected by PPX administration at the p < .01 level. 
 
The bottom left graph in Figure 3-5 shows that bias, measured as log b, was minimal (i.e., 
near zero) during the chronic saline (M = -0.05, SD = 0.25) and PPX (M = 0.00, SD = 
0.32) regimens and was not significantly affected by drug administration. 
 Figure 3-5 (bottom right) also depicts the mean number of omissions recorded per 
session. During the last four sessions of the chronic saline regimen, no omissions 
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occurred. Conversely, the frequency of omissions increased significantly during the 
chronic PPX regimen (M = 7.42, SD = 8.36), z = -2.93, p < .01, ES = .60. 
Discussion 
 Experiment 2 explored the possibility that PPX reduces rats’ discrimination of 
response-reinforcer contingencies. Rats were trained to symbolically relate samples (left 
or right levers) to arbitrary comparisons (left or right nose poke operanda). Accuracy of 
rats’ discrimination of the response-reinforcer contingencies was perfect for half of the 
subjects and nearly so for other subjects under chronic saline conditions. At the group 
level, chronic PPX (0.18 mg/kg) administration reduced accuracy of the discrimination 
and increased the frequency of omitted trials. 
 Perfect accuracy of the discrimination of the source of reinforcement in the SMTS 
task indicates that subjects correctly attend to and identify contingencies relating the 
productive response to the reinforcer delivered to the centralized food receptacle. 
Conversely, the decrements observed with PPX administration suggest that during drug 
sessions subjects occasionally misattributed reinforcement obtained from the just-
productive response to the nonproductive response. Impairment of the discrimination, 
however, was not so severe as to completely disrupt discrimination (i.e., a log d value of 
0, or 50% accuracy). Instead, accurate discriminations decreased by approximately 14%. 
 Moderately impaired discrimination of response-reinforcer contingencies 
observed in Experiment 2 may in part explain the results of Experiment 1. Procedural 
differences between the two experiments, however, suggest that this discrimination might 
be less impaired in Experiment 1 than in Experiment 2. First, a COD was programmed in 
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Experiment 1 to discourage rapid switching between the left and right levers. As a result, 
rats tended to engage in response bouts on a single lever prior to being granted terminal-
link access. When tasked with discriminating response-reinforcer contingencies, extended 
exposure to the ultimately-productive response (in this case, by means of a response bout) 
may facilitate accuracy, as reported in nonhuman studies of memory in which sample 
repetition or duration was manipulated (Grant, 1976; Roberts, 1972a; White & Wixted, 
1999). Second, upon earning terminal-link access in Experiment 1, the stimulus lamp 
above the productive alternative (left or right lever) remained illuminated, providing a 
stimulus that bridged the delay to reinforcement that might otherwise impair 
discrimination of the response-reinforcer contingency. Indeed, a small literature suggests 
that the effects of d-amphetamine, an indirect dopamine agonist, on intertemporal choice 
are modulated by the presence or absence of a stimulus during the LL delay (Cardinal, 
Robbins, & Everitt, 2000; but see, Helms, Reeves, & Mitchell, 2006). By comparison, the 
deficit in accuracy may have been more pronounced in the SMTS procedure in 
Experiment 2 because only a single sample response was required and there were no 
stimuli programmed that could have bridged the response and reinforcer delivery, the 
combination of which predicts a greater likelihood for disrupted discrimination. 
 The present findings suggest that PPX-induced changes in intertemporal choice 
(Chapter 2; Koffarnus et al., 2011; Madden et al., 2010) may have been affected by 
disruptions in response-reinforcer contingency discrimination. As discussed above, the 
context in which this discrimination occurs may determine the severity of disruption. One 
variable known to affect the accuracy of discrimination is the extent to which differential 
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outcomes are provided for each response (Jones & White, 1994; Nevin, Ward, Jimenez-
Gomez, Odum, & Shahan, 2009; Savage & Parsons, 1997). Therefore, by virtue of 
differences in reinforcer delay and amount provided for each choice response (i.e., 
differential outcomes), the accuracy of response-reinforcer contingency discrimination in 
intertemporal choice should be less prone to disruption than accuracy in Experiment 1, 
which featured only differences in delay to reinforcement. Moreover, the degree to which 
stimulus features differ from one another along a common dimension (i.e., 
discriminability) should influence the extent of disruption. Because reinforcer delays in 
Experiment 1 were more similar (3 vs. 12 s) than reinforcer delays in Chapter 2 (0.01 s 
vs. 10, 20, or 30 s), performance in Experiment 1 may have been more easily disrupted 
than intertemporal choice in Chapter 2. 
According to the differential-outcomes effect, differences in reinforcer amount 
may facilitate response-reinforcer contingency discrimination in an intertemporal choice 
situation (e.g., 3 pellets always follow a right-lever response). However, amount 
discrimination could also be impaired by PPX administration. As outlined in Figure 1-4, 
if a drug disrupts amount sensitivity in an intertemporal choice task, then according to 
Equation 8, response allocation will not as strongly favor the larger of the two reinforcer 
amounts. As sensitivity to relative reinforcer amount is increasingly impaired, 
intertemporal choice should become increasingly determined by differences in reinforcer 
delays and preference should shift toward the more immediate (SS) reward. Furthermore, 
if PPX disrupts amount discrimination, then the differential outcomes that may have 
otherwise facilitated discrimination of the source of reinforcement may be rendered 
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ineffective. In such a scenario, disruption of amount discrimination may exacerbate the 
disruption of response-reinforcer contingencies. For these reasons, examining the effects 
of chronic PPX on amount discrimination was the goal of Experiment 3. 
Experiment 3 
Introduction 
In the absence of delays to reinforcement, organisms exhibit natural preferences 
for larger over smaller reinforcer amounts (e.g., initial-block choice in Chapter 2 and 
Koffarnus et al., 2011). In an intertemporal choice, however, preference for a larger 
amount of reinforcement competes with preference for immediate over delayed 
reinforcement. If small and large reinforcer amounts are perfectly discriminated in an 
intertemporal choice, then the difference in reinforcer amounts will have its maximal 
effect on choice. If, however, amount discrimination is compromised, the ratio of the two 
reinforcer amounts may appear subjectively less than is objectively the case as reflected 
in response allocation. With differences in reinforcer amount effectively minimized, 
intertemporal choice is free to be governed almost entirely by differences in reinforcer 
delay. Under these circumstances, choice for the more immediate SS reinforcer would be 
expected to increase. Additionally, poor amount discrimination may further impair other 
discriminations germane to intertemporal choices, such as the contingency relating which 
response produced a particular amount of reinforcement (i.e., response-reinforcer 
contingency). 
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 Impaired amount discrimination provides an additional and perhaps 
complementary explanation for the findings of PPX-induced increased SS choice in 
intertemporal choice experiments. For instance, in Koffarnus et al. (2011) and in Chapter 
2 of the present research, high PPX doses (0.1-0.32 mg/kg) increased SS choice in the 
initial trial block in which rats chose between small and large reinforcer amounts, both 
available immediately. Because nondrug choice favored almost exclusively the larger 
reinforcer in both cases, the direction of the PPX-induced shift in preference for this 
alternative suggests that discrimination of reinforcer amounts may have been 
compromised. Diminished amount discrimination could also explain the results of the 
Madden et al. (2010) study in which PPX increased preference for the SS reinforcer in a 
dose-dependent manner. This increase in impulsive choice could be due to increased 
sensitivity to relative reinforcer delay (a hypothesis not supported by Experiment 1) or a 
diminished ability to discriminate large from small reinforcers. If PPX impaired amount 
discrimination and thus made subjectively more equal the reinforcer amounts (1 and 3 
food pellets), then choice would be more strongly influenced by the intact difference in 
reinforcer delay and favor the SS reinforcer. The same could be said for Madden and 
others’ (2010) “impulsive” baseline, although a ceiling effect on SS choice may have 
prevented the detection of this effect. 
 To investigate the hypothesis that PPX impairs rats’ discrimination of different 
reinforcer amounts, Experiment 3 used the SMTS procedure employed in Experiment 2. 
The experimental question could not be evaluated using the concurrent-chains procedure 
of Experiment 1 because diminished amount discrimination is predicted to flatten the 
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matching function in a manner formally identical to a general impairment of stimulus 
control, an outcome which would fail to dissociate the two accounts. As discussed below, 
the SMTS procedure does not require rats to discriminate the source of reinforcement–
only the reinforcer amount obtained–and is therefore less confounded by impairments of 
other relevant discriminations. In our experiment, rats received response-independently 
either small or large food amounts (1 or 3 food pellets), which served as the sample 
stimulus. Following consumption, rats selected a left or right lever to report which 
sample was provided. The resulting measures of accuracy provided an individualized 
baseline performance against which the effects of chronic PPX were then compared. 
Methods 
Subjects and apparatus. The subjects and apparatus were those used in 
Experiment 2. A head entry detector (ENV-254-CB, Med Associates Inc., St. Albans, 
VT) was installed in the front pellet receptacle between Experiments 2 and 3 to precisely 
coordinate the onset of comparison stimuli. Animal use was in accordance with the 
Institutional Animal Care and Use Committee (IACUC) of Utah State University. 
Behavioral procedure. Experimental sessions consisted of 40 trials. For the first 
part of each trial, one of two food reinforcer amounts (1 or 3 pellets) was selected 
randomly without replacement to be delivered response-independently into the front 
receptacle (20 trials per reinforcer amount; sample period). Following consumption and 
an exit response from the food receptacle, an SMTS task was used to assess 
discrimination of the 1- and 3-pellet reinforcer amounts (comparison period). First, the 
left and right levers were inserted and their associated stimulus lights were illuminated. 
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Next, a conditional discrimination was required such that the rat needed to press the lever 
symbolically associated with the sample reinforcer amount (e.g., if 3 pellets were 
delivered, choose left lever); symbolic relations were counterbalanced across rats. Correct 
responses extinguished all stimuli and resulted in the delivery of 1 food pellet to the front 
receptacle. Incorrect responses produced the same series of events with a 0.5-s blackout 
taking the place of pellet delivery. Following each trial, a 30-s ITI occurred during which 
all stimuli were in the off-state. Failure to emit a comparison response within 15 s of 
lever activation resulted in trial termination and the trial being counted as an omission. 
For the first 10 sessions of the experiment, a correction procedure was 
implemented. During this period, trials in which samples were not identified correctly 
were repeated indefinitely until the correct discrimination was made. Sessions ended once 
40 correct discriminations were made or 2 hours had elapsed. The correction procedure 
was then removed for 10 sessions, after which the chronic PPX assessment began 
regardless of baseline accuracy. 
Drug procedure and data analysis. With the exception of the order of saline and 
PPX regimens (opposite those experienced in Experiment 2), drug procedures and 
analytical techniques were identical to those used in Experiment 2. Log d and log b 
calculations were modified from Equations 10 and 11 to yield amount-specific 
formulations: 
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In Equations 12 and 13, RSS and RLL correspond to trial counts for correct discriminations 
of small and large samples, respectively; RSL and RLS are trials on which subjects reported 
incorrectly small and large samples. Statistical comparisons used Wilcoxon signed-ranks 
tests with an alpha level of .05. Effect sizes were calculated according to the method 
described by Field (2009). 
Results 
 Behavioral measures are displayed in Table 3-6. Figure 3-6 (top left) shows that 
chronic PPX (0.18 mg/kg) administration significantly reduced the accuracy of rats’ 
discrimination of the different reinforcer amounts (log d; M = 0.77, SD = 0.26), z = -2.63, 
p < .01, ES = .54. Calculated as the percentage of trials on which a correct amount 
discrimination occurred, rats reported the sample correctly on 93.3% (SD = 2.99) and 
84% (SD = 7.09) of trials in the chronic saline and PPX regimens, respectively. Thus, 
PPX reduced accuracy of the discrimination from nondrug levels by an average of 9.23% 
(SD = 8.40). 
When considered separately, the accuracy with which rats reported small 
reinforcer sample trials (M = 95.11, SD = 4.20) was significantly higher than accuracy on 
large reinforcer sample trials (M = 91.47, SD = 3.66), z = -2.25, p < .03, ES = .46 (data 
not shown). PPX administration reduced accuracy from nondrug levels by 11.26% (SD = 
8.44) and 7.76% (SD = 11.74; p > .13) to 83.95% (SD = 7.57) and 83.49% (SD = 11.86) 
in small and large sample trials, respectively. 
As shown in Figure 3-6 (bottom left), rats were biased in favor of reporting that 
the sample reinforcer was small (i.e., positive bias) under saline conditions. Chronic PPX 
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Table 3-6 
Parameter Estimates from Experiment 3 
 
Rat 
PPX 
(mg/kg) 
 
Log d 
 
Log b 
Percent 
correct (%) 
Percent left 
correct (%) 
Percent right 
correct (%) 
Omissions 
per session 
B1 Saline 1.16 0.00 93.75 93.75 93.75 0.00 (0.00) 
 0.18 0.74 -0.18 84.08 78.75 89.61 0.75 (0.65) 
        
B2 Saline 1.12 0.42 90.63 97.50 83.75 0.00 (0.00) 
 0.18 0.94 0.21 89.24 93.75 84.62 0.50 (0.43) 
        
B3 Saline 1.72 0.78 95.00 100.00 90.00 0.00 (0.00) 
 0.18 0.30 0.26 69.91 78.67 52.63 11.75 (2.10) 
        
B4 Saline 0.89 0.00 88.75 88.75 88.75 0.00 (0.00) 
 0.18 0.90 0.10 89.03 91.25 86.67 1.25 (0.65) 
        
B5 Saline 1.25 0.00 95.00 95.00 95.00 0.00 (0.00) 
 0.18 1.21 -0.05 94.38 93.75 95.00 0.00 (0.00) 
        
B6 Saline 1.04 -0.04 91.88 91.25 92.50 0.00 (0.00) 
 0.18 0.63 -0.11 80.67 76.92 84.72 2.50 (0.83) 
        
G1 Saline 1.13 0.24 92.50 96.25 88.75 0.00 (0.00) 
 0.18 1.12 0.04 93.13 93.75 92.50 0.00 (0.00) 
        
G2 Saline 1.83 0.68 96.88 100.00 93.75 0.00 (0.00) 
 0.18 0.66 -0.07 82.07 79.75 84.85 3.75 (0.54) 
        
G3 Saline 1.25 0.00 95.00 95.00 95.00 0.00 (0.00) 
 0.18 0.68 -0.12 82.35 78.48 86.49 1.75 (0.89) 
        
G4 Saline 1.31 0.06 95.63 96.25 95.00 0.00 (0.00) 
 0.18 0.50 -0.08 75.95 72.50 79.49 0.50 (0.43) 
        
G5 Saline 1.76 0.75 95.63 100.00 91.25 0.00 (0.00) 
 0.18 0.58 0.21 79.85 86.25 70.37 6.50 (0.90) 
        
G6 Saline 0.86 0.03 88.13 88.75 87.50 0.00 (0.00) 
 0.18 0.96 -0.27 87.39 83.54 95.00 10.25 (1.71) 
Note. Overall accuracy (calculated as log d and percentage correct), bias (log b), accuracy 
on small and large sample trials, and mean number of omissions per session at each 
chronic PPX dose for individual rats. Standard error of the mean of the final four 
administrations per dose is in parentheses. 
 
   
 
 
  99 
  
 
Figure 3-6. Effects of chronic saline and PPX administration on behavioral measures in 
Experiment 3. Top left: Accuracy of rats’ discrimination of the reinforcer (i.e., sample) 
amount calculated as log d (see text). Top right: The same accuracy data calculated as 
percentage of correct discriminations. Bottom left: Bias for a given comparison response 
independent of experimenter-programmed variable calculated as log b (see text). Bottom 
right: Mean number of omissions per session. Single and double asterisks identify 
behavioral measures significantly affected by PPX administration at the p < .05 and p < 
.01 level, respectively. 
 
administration significantly reduced this bias (M = -0.01, SD = 0.17), z = -2.82, p < .01, 
ES = .58. 
As in Experiment 2, rats completed trials reliably under chronic saline conditions. 
The bottom right graph in Figure 3-6 shows that the frequency of omissions per session 
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increased significantly with chronic PPX administration (M = 3.29, SD = 4.06), z = -2.81, 
p < .01, ES = .57. 
Discussion 
 Experiment 3 was conducted to assess the effects of chronic PPX administration 
on rats’ discrimination of small and large reinforcer amounts. Chronic PPX 
administration reduced rats’ discrimination of the reinforcer amounts, affecting the 
percentage of small-sample trials matched correctly to a greater extent than large-sample 
trials. PPX also reduced nondrug bias, but increased the frequency of omitted trials. 
 That PPX reduced discrimination of different reinforcer amounts in the present 
experiment suggests an additional behavioral mechanism by which the drug might 
influence intertemporal choice. As discussed above, if an organism perceives smaller and 
larger reinforcer amounts as subjectively more similar following PPX administration, and 
discrimination of reinforcer delays is preserved, then choice is predicted to increasingly 
favor the SS reinforcer because this alternative is delivered immediately. Compared to 
the magnitude of the disruptions in choice observed by Madden et al. (2010), Koffarnus 
et al. (2011), and in Chapter 2–that is, disruptions sufficient to shift choice toward 50% or 
indifference–the disruption of amount discrimination in Experiment 3 was modest. That a 
disruption of this magnitude alone accounts for the collective results is unlikely, although 
differences in the duration of PPX administration (acute vs. chronic) may partially 
account for the discrepancy. It could also be the case that poor amount discrimination 
exacerbates the discrimination of response-reinforcer contingencies in intertemporal 
choice situations. That is, if reinforcer amounts serve discriminative functions that aid the 
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organism in relating reinforcement earned to the response that produced reinforcement, 
then the absence of differential stimuli may further reduce accurate discrimination of 
operative contingencies. Even so, the formal manner in which disruption of amount 
discrimination interacts with disruption of response-reinforcer contingency 
discrimination is unclear and remains a point of speculation. 
General Discussion 
 Across three experiments, putative behavioral mechanisms underlying the effects 
of acute and chronic PPX on intertemporal choice were investigated in an effort to 
provide a unified explanation for the divergent findings of Madden et al. (2010), 
Koffarnus et al. (2011), and Chapter 2. Those divergent findings are as follows:  
1. Madden et al. (2010) reported that PPX (0.1-0.3 mg/kg) increased SS choice in a 
baseline condition of nondrug LL reinforcer preference, but not in a control condition of 
nondrug SS reinforcer preference; 
2. Koffarnus et al. (2011) and Chapter 2 reported that PPX (0.1., 0.18, 0.3, and 0.32 
mg/kg) increased preference for the SS reinforcer primarily when the larger reinforcer 
was not delayed (0 s trial block of the increasing-delay procedure) and generally shifted 
preference toward indifference (50% choice) in subsequent trial blocks. 
In Chapter 3, behavioral processes relevant to intertemporal choice were 
experimentally isolated to quantify the effect of PPX on each process independently. To 
the extent that the effects observed across these experiments generalize to the more 
complex procedural arrangements characterizing intertemporal choice studies, the present 
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research may be in a position to explain why PPX produces the divergent profile of 
behavioral outcomes summarized above.  
The logic outlined in Figure 1-3 suggests that Finding 1 could be the product of 
increased sensitivity to relative reinforcer delays to the LL and SS reinforcers. That is, 
increased delay sensitivity means the value of the LL reinforcer would be discounted 
more severely, resulting in increased preference for the SS reinforcer. This account was 
not supported by the results of Experiment 1. Instead, sensitivity to relative reinforcer 
delay was decreased by acute PPX, whereas chronic PPX did not affect sensitivity. Thus, 
no evidence was obtained to suggest that Finding 1 is the product of hypersensitivity to 
reinforcer delay. Rather, the manner in which delay sensitivity was affected by PPX 
suggests a disruption of stimulus control over choice behavior, an account consistent with 
Finding 2. 
 Experiments 2 and 3 were designed to investigate specific components of 
stimulus control that may have been disrupted by chronic PPX. Discriminated 
performance requires that the organism accurately characterize the contingency relating 
the response and the reinforcer it produces. If the accuracy of this discrimination was 
impaired in Experiment 1 (as well as in previous intertemporal choice studies), some 
reinforcers would be attributed falsely to the other programmed operant responses. This 
hypothesis was supported in Experiment 2 as chronic PPX administration modestly 
decreased the accuracy of rats’ discrimination of a simple response-reinforcer 
contingency. Theoretically, the magnitude of such a disruption should depend upon the 
initial discriminability of the response alternatives. In Experiment 1, wherein the delays 
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to reinforcement were more similar (e.g., 3 vs. 12 s) than in traditional intertemporal 
choice studies (e.g., 0.01 vs. 10 s), it seems likely that misattribution was undifferentiated 
and therefore responsible for the progressive flattening of the matching function 
(although this effect was not seen with chronic PPX). Impairments in response-reinforcer 
contingency discrimination might also be accentuated by the presence of a delay 
separating the response from the reinforcer, as is the case with LL reinforcers. As a result, 
it may be more likely that LL reinforcers are misattributed to the SS choice response than 
vice versa. Differential misattribution of LL reinforcers could explain Findings 1 and 2. 
In both cases, SS choice was increased by PPX, although with Finding 2 the drug-
induced shift was more indicative of a loss of stimulus control as the preference functions 
of Koffarnus et al. (2011) and Chapter 2 shifted toward indifference. The upward shift in 
LL choice at longer LL delays in Chapter 2 is not, however, consistent with the 
differential-misattribution hypothesis and instead suggests that reinforcers were 
misattributed with greater equality across the response alternatives. 
 An alternative explanation for Findings 1 and 2 was that rats’ discrimination of 
differences in reinforcer amounts was disrupted by PPX, and the results of Experiment 3 
revealed such a disruption. If reinforcer amounts are discriminated imperfectly, then 
intertemporal choice should be governed increasingly by differences in reinforcer delay 
(i.e., shifting preference toward the SS alternative, Finding 1), assuming this 
discrimination remains unaffected by the drug. Poor amount discrimination should also 
shift choice between a small and a large reinforcer toward indifference (Finding 2). Poor 
amount discrimination could also complement and exacerbate impairments in other 
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critical discriminations. For example, through the removal of discriminative stimuli (i.e., 
differences in reinforcer amount) the discrimination of response-reinforcer contingencies 
could be increasingly impaired in the absence of amount-related cues.   
 Across three experiments, the effects of PPX administration were most consistent 
with an account based on impaired stimulus control. That is, two behavioral processes 
likely to be recruited during intertemporal choice were negatively affected by acute and 
chronic PPX administration. Impairment of one these processes, amount discrimination, 
not only predicts greater SS choice but may also interact with and further impair another 
process, discrimination of response-reinforcer contingencies, through the removal of 
critical discriminative stimuli (i.e., differences in reinforcer amount). Confidence in this 
account should be tempered by five limitations of the present line of research. First, the 
procedures using in Experiments 1-3 were designed to isolate single behavioral 
processes; as such, the results of these experiments may not reveal the interactions 
between these processes that contributed to the findings of previous studies.  
 Second, the concurrent-chains procedure used in Experiment 1 was designed to 
isolate the effects of relative reinforcer delays on response allocation, but as 
demonstrated in Experiment 2 was likely also influenced by negative effects of PPX on 
discrimination of response-reinforcer contingencies. As such, the procedure may not have 
provided a valid index of the drug effect on delay sensitivity independent of other 
behavioral perturbations. Use of an SMTS procedure with delays as sample stimuli or a 
temporal bisection task (Church & Deluty, 1977) could have addressed this procedural 
shortcoming and resulted in an unadulterated measure of delay discrimination. Third, the 
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interpretation of previous findings based on impairments in discrimination processes 
involved in intertemporal choice provided above assumes in part that rats’ discrimination 
of reinforcer delays remains intact to influence SS choice. Delay discrimination, 
however, was not explicitly assessed in the present study. Evidence to suggest that delay 
discrimination was not disrupted by PPX may come from Experiment 1, in which the 
same chronic PPX dose used in Experiments 2 and 3 did not significantly affect delay 
sensitivity. The lack of an effect on delay sensitivity, a behavioral process presumably 
based on an organism’s ability to discriminate differences in reinforcer delays, suggests 
that delay discrimination may have remained intact following PPX administration. 
Despite this reasoning, if future studies reveal delay discrimination to be comparably 
impaired by PPX, then an interpretation based solely on impairment of amount and 
response-reinforcer contingency discriminations should be reconsidered, as global 
impairment of all discriminations predicts shifts in choice toward indifference in not only 
the increasing-delay procedure, but also the fixed-delay procedure used by Madden et al. 
(2010). Fourth, the chronic PPX dose of 0.18 mg/kg was chosen for examination because 
this dose produced behavioral effects in previous studies and with fewer omissions than 
the highest PPX dose (0.3 mg/kg). Investigation of chronic PPX is important for its 
resemblance to the regimens of clinical patients and should be parametrically examined 
across a wider dose range to accurately describe its effects at both low and high doses. 
Finally, Experiments 2 and 3 were conducted using the same subjects, a decision which 
may have reduced baseline accuracy in the amount discrimination task which was 
completed after the contingency discrimination task. Within-subject manipulations allow 
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researchers to reduce the number of subjects used, but may also compromise behavioral 
performances if historical variables are prone to interference. 
 Acute and chronic PPX affected behavioral processes potentially involved in 
intertemporal choice. Disruptions in two discrimination processes, response-reinforcer 
contingency and amount discrimination, were implicated as candidate behavioral 
mechanisms that could have produced the effects of PPX observed in previous 
intertemporal choice studies. An interpretation of the drug effect based on poor stimulus 
control may prove satisfactory for nonhuman experiments, but is unfortunately silent with 
respect to the occurrence of ICDs in clinical populations taking DA agonist medications 
like PPX. The procedures incorporated herein could easily be exported for use in humans 
and as such may further elucidate the generality of the behavioral mechanisms identified 
in the present work. 
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CHAPTER 4 
SUMMARY AND CONCLUSIONS 
 The present set of experiments was designed to address two research questions 
related to the effects of the dopamine agonist medication PPX on rats’ intertemporal 
choices as reported in Madden et al. (2010) and Koffarnus et al. (2011). Given the 
contradictory nature of these two findings, the first research question targeted the 
conditions under which the drug increased impulsive choice, but also nonspecifically 
disrupted behavior (as in Koffarnus et al., 2011). The second research question was 
aimed more broadly at the elucidation of behavioral mechanisms underlying the PPX 
effect on intertemporal choice. The ultimate goal of the research was to identify a 
behavioral process or processes affected by the drug that was capable of providing a 
common explanation for the mixed PPX literature. 
Contrary to the report by Madden et al. (2010), Koffarnus et al. (2011) suggested 
that in addition to increasing the probability of SS choice, acute PPX might also disrupt 
choice behavior vis-à-vis stimulus control. To address this interpretation, the experiment 
presented in Chapter 2 attempted to systematically replicate the behavioral profile of PPX 
in an increasing-delay procedure similar to the one employed by Koffarnus et al. (2011). 
In an effort to decrease the likelihood that rats’ choices were based on the passage of time 
within the session (rather than LL delays) or that choice reflected idiosyncratic lever 
biases, intermittent no-delay sessions and a centering response were added to the 
experimental protocol of Chapter 2. The results were formally consistent with those 
reported by Koffarnus et al. (2011): At high doses (0.1-0.3 mg/kg), acute PPX shifted 
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preference functions toward indifference, even in the initial trial block in which both 1- 
and 3-pellet reinforcers were available immediately. Furthermore, lower PPX doses (0.01 
and 0.03 mg/kg) did not significantly affect choice. Relative to acute PPX, chronic PPX 
(0.1 and 0.3 mg/kg) did not disrupt initial-block choice, suggesting that repeated 
administration of the drug may ameliorate some of its disruptive effects on behavior. 
Chapter 3 outlined an approach for identifying behavioral processes critical for 
intertemporal choice which, if affected by PPX, could have produced the pattern of PPX 
effects as reported by Madden et al. (2010), Koffarnus et al. (2011), and in Chapter 2. 
Experiment 1 tested the hypothesis that PPX increased rats’ SS choice in the Madden et 
al. (2010) experiment by increasing their sensitivity to relative reinforcer delay. By 
examining response allocation in a concurrent-chains procedure and by modeling choice 
using the generalized matching law, Experiment 1 revealed that acute, but not chronic, 
PPX decreased rats’ delay sensitivity, a finding inconsistent with an outcome of greater 
SS choice. An alternative explanation of these findings suggested that PPX disrupted the 
accuracy with which rats discriminated the response-reinforcer contingencies in the 
concurrent-chains procedure and possibly in intertemporal choice procedures as well. 
Experiment 2 used a symbolic matching-to-sample task to assess the chronic drug effect 
on rats’ reporting of which response (left or right lever press) produced reinforcement. 
PPX decreased the accuracy of rats’ discrimination of response-reinforcer contingencies. 
Experiment 3 evaluated an alternative but potentially complementary behavioral 
mechanism, specifically rats’ discrimination of different reinforcer amounts (1 vs. 3 
pellets) under chronic PPX conditions. In a similar manner to the way in which PPX 
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negatively affected the discrimination in Experiment 2, PPX decreased rats’ accuracy 
with respect to amount discrimination. Collectively, these experimental findings 
emphasize the potential for PPX to impair discrimination processes thought to be critical 
in intertemporal choice. 
Based on the results of Chapter 3, an explanation for the behavioral patterns 
induced by PPX as observed in previous intertemporal choice studies was provided based 
on impaired discrimination processes. Recall that in an intertemporal choice an 
organism’s “default” preferences for immediate and greater quantities of reinforcement 
are set in conflict with one another by virtue of the SS and LL choice alternatives. An 
important consequence of this conflict is that if PPX impairs an organism’s ability to 
discriminate differences in any one of these stimulus dimensions, then choice should 
become increasingly determined by any discrimination that remain unaffected by the 
drug. For instance, if PPX were to impair the discrimination of reinforcer amounts and 
delay discrimination remained intact (as suggested by the nonsignificant results of 
chronic administration on delay sensitivity in Experiment 1), then choice should 
increasingly favor the SS reinforcer because it is delivered relatively sooner than the LL 
reinforcer. However, if PPX globally impairs discrimination of the choice alternatives 
(i.e., subjects cannot discriminate relative amounts, delays, or other relevant differences), 
then choice should trend toward indifference (i.e., 50% choice). Empirically, although a 
dose-dependent trend toward indifference was observed by Koffarnus et al. (2011) and in 
Chapter 2, Madden et al. (2010) reported that only choice in one of two baseline 
conditions was affected by PPX. This latter finding suggests that if PPX does disrupt 
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choice behavior by impairing a discrimination required for intertemporal choice then at 
least one discrimination must remain intact to govern choice. 
 According to the results of Experiment 2, PPX negatively affects the 
discrimination of response-reinforcer contingencies in a manner that would appear to 
partially explain the decrease in delay sensitivity observed in Experiment 1. Research in 
nonhuman memory using similar matching-to-sample procedures demonstrates that by 
introducing a delay (i.e., retention interval) between the sample stimulus to be 
remembered and the comparison stimulus the accuracy of a discrimination is diminished 
(e.g., Chrobak & Napier, 1992; White, 1985). By extension, in an intertemporal choice, 
the LL delay separating the choice response from reinforcer delivery may decrease the 
likelihood that LL reinforcers are attributed correctly to the LL choice response. 
Alternatively, because SS reinforcers are delivered almost immediately after the choice 
response, the response-reinforcer contingency is unlikely to be as negatively affected by 
an intervening delay and SS reinforcers are putatively attributed with greater accuracy. 
As a result, a hypothesized outcome of impaired discrimination of response-reinforcer 
contingencies (i.e., misidentification of the source of obtained reinforcement) is that LL 
reinforcers are differentially misattributed to the SS choice response, but not vice versa. 
Once misattributed, perhaps in the course of experiencing forced-choice trials, 
misattributed LL reinforcers may artificially inflate the frequency of SS choice. 
 Along with delay to reinforcement, the amount of reinforcement delivered for 
each alternative also differs in an intertemporal choice. If an organism poorly 
discriminates response-reinforcer contingencies as the results of Experiment 2 suggest, 
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then intact discrimination of the different reinforcer amounts may provide a supplemental 
discriminative stimulus to guide future choices. That is, in the event that a LL delay 
decreases the likelihood that an organism correctly attributes the LL reinforcer to the LL 
choice response, then the intact discrimination of the LL reinforcer amount (e.g., 3 
pellets) upon its delivery may counteract the impairment in contingency discrimination. 
However, as was demonstrated in Experiment 3, PPX also disrupted rats’ discrimination 
of reinforcer amount (1 vs. 3 pellets). Such a drug effect has two apparent consequences 
on choice behavior. First, if reinforcer amounts are less than perfectly discriminated in an 
intertemporal choice, then choice may become increasingly dependent upon differences 
in reinforcer delay. Assuming that organisms prefer reinforcement to be delivered sooner 
rather than later, choice in drug sessions should increasingly favor the SS reinforcer. 
Second, if PPX impairs amount discrimination, then reinforcer amount differences cannot 
serve their discriminative function to aid the attribution of reinforcers to responses. As a 
result, given the predicted effects of LL delays on discriminated performance, occasional 
misattribution of LL reinforcers may further exacerbate an organism’s tendency to select 
the SS choice alternative. 
 The above interpretation of PPX’s effects on discrimination processes underlying 
intertemporal choice accords not only with the findings presented herein but also with 
previous reports of increased SS choice (Madden et al., 2010) and nonspecific disruption 
(Chapter 2; Koffarnus et al., 2011) following PPX administration. In the study by 
Madden et al. (2010), acute PPX significantly increased rats’ choice for the SS reinforcer 
in a nondrug baseline condition of predominantly LL reinforcer choice. The opposite 
   
 
 
  112 
  
effect (i.e., a decrease in SS choice) was not observed in a control baseline condition of 
predominantly SS reinforcer choice, a finding that indicated the absence of any 
nonspecific effects (e.g., poor discrimination between the choice alternatives). How do 
the results of Madden and others’ (2010) study conform to an interpretation of the drug 
effect in terms of impaired discrimination processes? In the “self-control” baseline 
condition (i.e., predominant LL choice), a PPX-induced disruption of response-reinforcer 
contingency and amount discriminations is predicted to produce an increase in SS choice, 
which was observed as an increasing function of PPX dose. In the “impulsive” baseline 
condition (i.e., predominant SS choice), the same disruptions are also predicted to 
increase SS choice. However, because baseline preference already favored this 
alternative, the lack of a PPX effect on SS choice may have represented a ceiling effect. 
Thus, in both baseline conditions, SS choice is increased by the drug as a result of 
impaired contingency and amount discrimination as well as by intact discrimination of 
reinforcer delays. 
 Koffarnus et al. (2011) and Chapter 2 found that acute PPX shifted preference 
functions toward indifference, regardless of whether a LL delay was in effect or not. In 
the initial trial block, rats chose between 1 or 3 pellets delivered immediately. In saline 
sessions, data from this initial block reflected a near exclusive preference for the 3-pellet 
reinforcer. Following PPX administration, this preference was disrupted and trended 
toward indifference as a function of increasing PPX dose. Decreased preference for a 
larger over a smaller reinforcer in the absence of any delay is consistent with an 
interpretation involving some impairment of amount discrimination. If discrimination of 
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differences in reinforcer amounts was the only discrimination disrupted by the drug, then 
one might predict a shift in only the y-intercept of the preference functions. However, 
these researchers observed a progressive flattening of the preference function toward 
indifference. In the case of Koffarnus et al. (2011), SS choice increased following acute 
PPX (0.32 mg/kg) administration but only to the point of near indifference (i.e., 50% 
choice) in each trial block. Assuming that an impairment in the integrity of rats’ 
discrimination of response-reinforcer contingencies may have also been present in their 
study, the misattribution of LL reinforcers would be expected to increase with longer 
duration LL delays. If misattributed to the SS choice response, future SS choice may 
result and shift the preference function toward indifference. Although this explanation is 
in agreement with the Koffarnus et al. (2011) findings, differential misattribution of LL 
reinforcers to the SS choice response cannot fully explain the results of Chapter 2. 
Contrary to the saline preference function generated by Koffarnus et al. (2011) which 
remained above indifference regardless of LL delay, the saline preference function 
generated in Chapter 2 was relatively steeper, achieving approximate indifference at a LL 
delay of 20 s and approaching 20% LL choice at a LL delay of 30 s. If delayed LL 
reinforcers are more likely to be misattributed to the SS choice response than vice versa, 
then an increase in SS choice should have been visible. Instead, preference functions 
became increasingly shallow and moved closer to indifference: At short LL delays, SS 
choice increased, while at longer LL delays, LL choice increased. Such an outcome is 
incompatible with an explanation based on the proposed interaction between contingency 
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discrimination and reinforcer delay and suggests instead that misattribution of reinforcers 
was undifferentiated (i.e., occurred at the same frequency for SS and LL reinforcers). 
 Several shortcomings and limitations of the present set of experiments are 
noteworthy. First, interpretation of the effects of PPX in the context of intertemporal 
choice and matching-to-sample procedures as unique to the particular drug may be 
unwarranted as a reference compound was not used for comparative purposes. Although 
research investigating less specific dopamine agonists (e.g., d-amphetamine) has 
demonstrated drug-related increases in SS choice (Cardinal et al., 2000; Evenden & 
Ryan, 1996; Hand, Fox, & Reilly, 2008) and disruption of stimulus control (Bizot, 1997; 
Çevik, 2003; Odum & Ward, 2007; Slezak & Anderson, 2009), there are reports of the 
same drug class exerting opposite behavioral effects (e.g., decrease in SS choice; 
Cardinal et al., 2000; Wade, de Wit, & Richards, 2000). Moreover, because PPX has 
affinity for both D2 and D3 receptor subtypes, the neurobiological specificity of the 
behavioral effects documented herein remains to be elucidated. Administration of D2- or 
D3-selective antagonists prior to PPX administration may facilitate this pursuit. Second, 
although not reported in the results, locomotor-slowing effects of PPX were evident in 
each of the experiments. Consistent with this finding, Johnson et al. (2011), Koffarnus et 
al. (2011), and Madden et al. (2010) all reported longer choice latencies in PPX sessions 
compared to the same measure in saline sessions. There has been some evidence to 
suggest that chronic PPX administration reduces the degree of locomotor effects 
(Chernoloz et al., 2009; Maj et al., 2000), which was the primary rationale for the 
incorporation of chronic dosing into the present set of experiments. However, even 
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repeated drug administration produced longer latencies to emit a centering response and 
select a choice alternative (Chapter 2) or report a sample stimulus (Experiments 2 and 3) 
than those recorded during saline sessions (data not shown). Despite measures taken to 
reduce its influence, this nonspecific drug effect may have interfered with or confounded 
behavioral measures of processes that may have contributed to intertemporal choice 
independent of hypolocomotor effects. Experimental preparations that minimize 
nonspecific effects of PPX may permit the investigation of relevant behavioral processes 
in the absence of any impairment in responding. Finally, an interpretation of the present 
findings based on impaired discrimination processes requires that the discrimination of 
relative reinforcer delays remains unaffected by PPX administration. Unfortunately, an 
evaluation of the drug effect on delay discrimination was not included in the research 
agenda and therefore the assertion that this discrimination is preserved under drug 
conditions lacks empirical support. As a proxy measure, sensitivity to, but not 
discrimination of, relative reinforcer delays was examined in Experiment 1 of Chapter 3. 
Although the extent to which sensitivity and discriminability of environmental stimuli are 
related constructs is beyond the scope of the present discussion (see Sutton, Grace, 
McLean, & Baum, 2008 for some consideration of this topic), future research could 
resolve the question by administering PPX prior to a task in which temporal intervals 
must be discriminated. 
 By attempting to isolate and describe the drug effect on individual behavioral 
processes in rats, the generality of the research findings is limited with respect to clinical 
populations prescribed the drug and reports of impulsive behavior (e.g., pathological 
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gambling, hypersexuality). Based on the nature of the clinical occurrences, it was 
assumed that they were behaviorally and theoretically consistent with the phenomenon of 
impulsive choice. As was mentioned in Chapter 1, however, impulsive choice represents 
but one facet of impulsivity. Impulsive action, the inability to inhibit a prepotent 
response, may capture just as easily the functional relations present in clinical instances 
of PPX-induced impulsivity. The inter-changeability of these constructs serves only to 
underscore the complexity and ambiguity inherent in the clinical setting. 
 A systematic program of research was designed and undertaken to identify the 
behavioral effects of the dopamine agonist medication PPX on intertemporal choice in 
rats. Quantitative analyses based on models of choice (generalized matching law), 
impulsivity (delay discounting), and discriminated performance (signal detection) proved 
useful in demonstrating PPX-related deficits in behavioral processes thought to be critical 
to decision-making. Based on the findings, it was concluded that disruptions in rats’ 
discriminations of response-reinforcer contingencies and reinforcer amounts were 
primarily responsible for the effects of acute and chronic PPX in intertemporal choice 
experiments with rats (Koffarnus et al, 2011; Madden et al., 2010). Despite several 
shortcomings, the research findings emphasize the importance of elucidating behavioral 
mechanisms of drug action in an effort to understand complex clinical behavior. 
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2010 (Spring) Instructor, ABSC 489: Directed Readings in Choice, University 
of Kansas, Lawrence, KS. Enrolled: 4 
2009 (Fall) Instructor, ABSC 100: Introduction to Applied Behavioral 
Science, University of Kansas, Lawrence, KS. Enrolled: 151 
2009 (Summer) Instructor, ABSC 100: Introduction to Applied Behavioral 
Science, University of Kansas, Lawrence, KS. Enrolled: 18 
2009 (Spring) Instructor, ABSC 499: Readings in the Experimental Analysis of 
Behavior, University of Kansas, Lawrence, KS. Enrolled: 4 
2008 (Fall) Co-instructor, ABSC 100: Introduction to Applied Behavioral 
Science, University of Kansas, Lawrence, KS. Enrolled: 160 
2008 (Summer) Instructor, ABSC 100: Introduction to Applied Behavioral 
Science, University of Kansas, Lawrence, KS. Enrolled: 20 
2007 (Fall) Co-instructor, ABSC 100: Introduction to Applied Behavioral 
Science, University of Kansas, Lawrence, KS. Enrolled: 125 
2007 (Summer) Instructor, ABSC 100: Introduction to Applied Behavioral 
Science, University of Kansas, Lawrence, KS. Enrolled: 20 
 
TEACHING ASSISTANTSHIPS 
 
2011 (Spring) PSY 1010: Introduction to Psychology, Utah State University, 
Logan, UT 
2010 (Fall) PSY 1010: Introduction to Psychology, Utah State University, 
Logan, UT 
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2010 (Spring) ABSC 100: Introduction to Applied Behavioral Science, 
University of Kansas, Lawrence, KS 
2008 (Spring) ABSC 100: Introduction to Applied Behavioral Science, 
University of Kansas, Lawrence, KS 
2007 (Spring) ABSC 100: Introduction to Applied Behavioral Science, 
University of Kansas, Lawrence, KS 
 ABSC 509: Contemporary Behavioral Science: Historical, 
Conceptual, and Comparative Foundations, University of Kansas, 
Lawrence, KS 
2007 (Fall) ABSC 509: Contemporary Behavioral Science: Historical, 
Conceptual, and Comparative Foundations, University of Kansas, 
Lawrence, KS 
2006 (Fall) ABSC 509: Contemporary Behavioral Science: Historical, 
Conceptual, and Comparative Foundations, University of Kansas, 
Lawrence, KS 
 
SERVICE 
EDITORIAL 
 
2011 Guest reviewer, Pharmacology, Biochemistry, and Behavior 
2009 Guest reviewer, Journal of Applied Behavior Analysis 
2009 Guest reviewer, Behavioral Pharmacology 
2008 Guest reviewer, Journal of the Experimental Analysis of Behavior 
 
DEPARTMENTAL 
 
2011 Student Search Committee Member, Assistant/Associate Professor in 
Behavioral Neuroscience, Department of Psychology, Utah State 
University, Logan, UT 
2011-2012 Student Representative, Experimental and Applied Psychological 
Science, Department of Psychology, Utah State University, Logan, UT 
2010-2011 Administrator, Sona Human Subject Pool Database 
Utah State University, Logan, UT 
2007-2009 Secretary, Applied Behavioral Science Graduate Student Organization 
University of Kansas, Lawrence, KS (2 terms) 
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